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epidemiology
Squamous cell carcinoma of the oral cavity (SCCOC) accounts for about 500 newly 
diagnosed patients in the netherlands each year; it represents 0,9% of all yearly newly 
diagnosed cancers and is the most common head and neck tumor in the netherlands1. 
the number of patients diagnosed with this type of cancer has increased with an average 
of about 3.5% every year from 1989-19981; this is mainly due to changes in populational 
build-up. 
etiology
The vast majority (about 90%) of OC cancers is of the squamous cell-type. Other types 
are malignant melanoma, mucoepidermoid carcinoma and adenoid cystic carcinoma. 
use of alcohol, tobacco and chewing of betel nut, indisputedly are predisponding factors 
in case of squamous cell carcinoma2-5; other influencing factors might be the consumption 
of high amounts of salted meat and a high amount of fruit with a negative and a positive 
influence respectively6, 7. 
anatomy
The oral cavity contains 7 anatomic subsites: lips (mucosal part), buccal mucosa, alveolar 
processes, floor of the mouth, anterior two thirds of the tongue (‘oral tongue’), retromolar 
trigone and hard palate. The posterior boundary is an imaginary line drawn from the 
border between the hard and the soft palate towards the circumvillate papillae; the 
anterior boundary is formed by the vermilion border of the lips (see figures 1 and 2). 
 
Figure 1: Oral cavity (box) Figure 2: oral cavity
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one third of all lymphatic nodes a human possesses is situated in the head and neck 
region; dissemination of metastatic cells in cancer of the head and neck occurs mainly 
through lymphogenic spread and so these nodes play a crucial role: knowlegde of 
lymphatic drainage is eminent. When metastatic lymph nodes are present in the neck in 
SCCoC, overall survival decreases by 50%8,9, so the need to diagnose (and treat) these 
nodes seems obvious.
Each patient suffering from head and neck squamous cell carcinoma (HNSCC) in the 
Netherlands is staged according to the international Tumor Node Metastasis (TNM) 
classification of the Union for International Cancer Control (UICC) and American Joint 
Committee on Cancer (AJCC)10: both the primary tumor and the regional involvement of 
lymph nodes (in the neck) play an important role, as does the presence of distant metastatic 
spread. Neck staging is based on the size, side of the neck and number of affected nodes: 
the location of metastatic spread within the neck is not taken into account, although this 
might have a substantial influence on treatment and outcome. Neck levels are usually 
categorized according to a classification system developed by the american academy of 
Otolaryngology & Head and Neck Surgery (table 1 and figure 311).
level containing
ia
ib
Submental nodes
Submandibular nodes, containing submandibular gland
iia
iib
upper jugular nodes anterior to accessory nerve
upper jugular nodes posterior to accessory nerve
iii mid-jugular nodes
iv lower jugular or supraclavicular nodes
v posterior triangle nodes
vi
prelaryngeal nodes
pre-/paratracheal nodes
Table 1: different neck levels and their nodes  
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Figure 3: anatomic location of neck levels 
lymphatic drainage
Basic studies by lindberg12 and Shah13 demonstrated that SCCoC lymphatically tends 
to spread in a predictable way. According to Shah, who performed 192 radical neck 
dissections (RND) in patients suffering from SCCOC having a cN0 neck (with no clinically 
palpable metastases), these tumors mainly spread to level I-III13. These findings indicate 
that selective removal of the nodes in these specific levels should remove the vast majority 
of possibly tumor-positive nodes. However, a number of authors14-16 emphasize that ‘skip 
metastases’ occur in a considerable amount of treated cN0 SCCOC patients: in these 
patients level I and II were not affected, while III and/or IV were. No consensus has been 
reached yet and the extent of neck dissection varies per medical center.
history of neck Dissection
a century ago, in 1906, george Crile17 was the first to introduce the rnd, a surgical 
technique still used nowadays. This technique has been used for some 60 years to treat 
any neck of patients with any form of known HNSCC. In the early 60’s, according 
to ferlito18, Suarez from argentina started treating certain patients by the so-called 
‘functional neck dissection’ (FND), as did Jesse and Ballantyne19 in the united States of 
America. This approach was further popularized and introduced to Europe by Bocca20. 
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Since then many forms of neck dissection have been described and advocated by various 
authors: certain kinds of neck pathology ask for certain kinds of neck dissection. in a 
widely accepted proposition by Weiss et al.21 it is estimated, by decision analysis, that as 
long as rates above 20% of occult metastatic spread still are found during histopathologic 
examination of a cN0-neck in SCCOC, a prophylactic selective neck dissection (SND) 
should be performed. Since no preoperative staging technique repeatedly and by different 
authors was found to reach below this 20%-level, the search for a preoperative staging 
technique able to identify these clinically occult metastases goes on. 
nomenclature of different operating techniques 
the rnd, as described by Crile17, encorporates the removal of all lymph nodes in neck 
levels I-V, applicable in all kinds of HNSCC. In RND the sternocleidomastoid muscle 
(SCM), internal jugular vein (IJV) and accessory nerve (AN) are removed. Removing 
these structures usually results in a high morbidity, covering diminished shoulder and 
neck movement and a decreased venous flow from the head22, 23. By preserving one, two 
or all of these structures in patients having cn0 necks, morbidity can be lowered; reason 
for this change were some detailed anatomical studies showing that neck structures like 
the SCM and the IJV were surrounded by fascia24. When this fascia and all overlying 
tissues are removed, the remaining structures probably will not harbour any metastases. 
a more reserved technique has shown to be accompanied by a lower morbidity and a 
higher quality of life25. After the introduction of SND, subclasses concerning both SND 
and RND rapidly were introduced, amongst which the ‘modified radical neck dissection’ 
(MRND). Generally nowadays a MRND comprises the removal of lymph nodes in region 
I-V; furthermore either the AN and/or the IJV and/or the SCM are being preserved. 
the type of neck dissection used depends on the location of the primary tumor plus its 
lymphatic drainage and the extent of neck disease. For a summary of the nomenclature 
see table 2. In 2002 Robbins et al.11 updated their formerly introduced classification and 
proposed that all types of SND should for instance be called ‘selective neck dissection 
comprising level I-III’ instead of the formerly used term ‘supraomohyoid neck dissection 
(SOHND)’. 
CHAPTER 1
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Type of  neck dissection levels cleared out Structures sacrificed
radical i-v AN, IJV and SCM
Modified Radical Type I i-v IJV and SCM
Modified Radical Type II i-v SCm
Modified Radical Type III 
(conservative neck dissection)
i-v none
extended neck dissection i-v + additional groups1 AN, IJV and SCM + extra2
selective (supraomohyoid) 
neck dissection
i-iii none
selective (extended 
supraomohyoid) neck dissection
i-iv none
selective (postero-lateral) neck 
dissection
ii-v none
selective (lateral jugular) neck 
dissection
ii-iv none
selective anterior (central) neck 
dissection
vi none
Table 2:  Types of neck dissection (modified from Robbins et al.11)
1: groups like paratracheal nodes or anterior compartment nodes 
2:  structures not usually removed like carotid artery, hypoglossal nerve and/or vagus nerve
staging-techniques
to treat a patient with SCCoC, one would like to know the extension of the disease, both 
local and regional, in order to adjust individualized therapy. Widely used preoperative 
neck staging techniques include palpation, ultrasound (US) with or without fine needle 
aspiration cytology (+/- FNAC), computed tomography (CT), magnetic resonance 
imaging (MRI) and positron emission tomography (PET) scanning. Recently sentinel 
lymph node biopsy (SLNB) has been added as a diagnostic tool. For these preoperative 
techniques a wide range of sensitivities and specificities have been found; unfortunately no 
matter what test is being used, false-negative rates are still high. Roughly 20 to 30 percent 
of the cN0-necks (meaning that preoperatively no proof of metastatic spread was present 
during palpation and any kind of imaging) contain histopathologically proven, metastatic 
lymph nodes in surgical resection specimens26-28. By preoperative investigation both high 
sensitivities and specificities are reached, but never combined in one technique. When 
more strict criteria for defining metastases are applied (raising specificity), this inevitably 
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leads to a drop in sensitivity (and the other way around as well). Postoperative staging by 
means of histopathological examination still counts as the ‘golden standard’.
histopathologic examination
Histopathologic examination in most cases consists of routine hemotoxylin- and eosin 
staining (H&E; mostly performed on slices of 2 to 3 mm with a thickness of 4µ). This 
technique renders less detailed and so probably less reliable information than for instance 
the examination of more slices per lymphnode (up to 0,5 mm per coupe) and/or the 
addition of immunohistochemistry29. Some authors even state that if these latter techniques 
would be standardized, the sensitivity of a lot of preoperative staging techniques would 
probably be lowered further30. 
us +/-Fnac
ultrasound can easily be combined with fnaC resulting in a high specificity being 
reached. Some authors, such as van den Brekel et al.31, 32, have reached good results with 
US +/-FNAC in the cN0-neck. This technique is based on tracking the largest nodes 
(which don’t have to be suspicious) or suspicious nodes on both sides of the neck by US and 
punctuate them for cytologic examination: minimal diameter of nodes to be punctured 
is 3-4 mm. Sensitivity for this staging technique in cN0 SCCOC, still only reaches 76%32 
and not all authors reach these high percentages33, 34.
cT and mri
along with uS, Ct and mri are long-known staging techniques; more thoroughly than by 
US, morphological characteristics of nodes can be depicted and interpreted. Also, CT and 
MRI images are more widely interpretable, not being dynamic imaging techniques. The 
presence or absence of extracapsular spread (ECS), a reknown bad prognosticator35, 36, can be 
estimated by both CT and MRI. Factors that also might indicate metastatic involvement 
of nodes are size (>10 mm smallest diameter), shape of the node (metastatic nodes tend 
to have a more rounded shape) and presence of irregular contrast enhancement due to 
tumor necrosis37. The latter characteristic is usually not present in small metastatic nodes; 
this explains why, in cn0-necks, size- and shape-criteria are mainly used for assessing 
neck status. However, any chosen size criterium will be a compromise between sensitivity 
and specificity: which axis to measure and which cutoff-points to use have been subject 
to a number of studies38-41. When focusing on staging of the palpably N0-neck, regardless 
CHAPTER 1
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of the kind of primary head and neck tumor, sensitivities and specificities for Ct range 
from 40-83% and 78-100% respectively37. These percentages range from 55-80 and 82-
92 respectively for conventional mri37, 42. 
FDg-PeT
the latest non-invasive diagnostic tool introduced to identify occult metastases is the 
Fluoro Deoxy Glucose (FDG)-PET-scan: a radioactively labeled glucose-derivative is 
injected into the bloodstream and accumulates in locations with a high glucose-usage. 
tumorous cells are known to consume a higher amount of glucose than non-tumorous 
cells and so will be depicted by the gamma-camera. In imaging primary N+ HNSCC 
fdg-pet has shown to be an accurate staging tool43-45. 
sentinel lymph node biopsy
A minimally invasive technique coming up is SLNB, as introduced by Morton et al.46 in 
melanoma. This technique is based on imaging the route of lymphatic flow. When a 
radio-active contrasting fluid is injected near the primary tumor, it will be flushed out by 
the lymphatic system in the vicinity of the tumorsite; when images are being made with 
certain intervals, the flow and direction of the lymphe, comparable to possible metastatic 
flow from the tumor, can preoperatively be pictured by means of lymphoscintigraphy or 
(more recently adapted) single photon emission computed tomography (SPECT). In this way 
the first echelon is discovered, peroperatively confirmed by a hand-held gamma probe and 
subsequently excised. Histopathological examination consisting of multi-slice sectioning and 
immunohistochemistry is performed: when metastatic proof is found, the second echelon will 
be subsequently treated. With absent proof of metastatic disease, the procedure is terminated. 
Paleri et al.47 performed a meta-analysis of studies regarding SLNB; their study ‘provided 
a firm evidence base for forthcoming trials on the role of SLNB in head and neck cancer’. 
recently, different authors have advocated the use of SlnB in low stage SCCoC48-50. Future 
results will clarify the role of SLNB in SCCOC. For an overview of preoperative staging 
techniques, see table 3.
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staging Technique  sensitivity (%)  Specificity (%)  accuracy (%)
Palpation 74 81 59 – 76
us 58 – 97 32 – 78 68 – 83
us +/-Fnac 48 – 98 95 – 100 79 – 89
cT 49 – 83 74 – 100 66 – 89
mri 33 – 64 69 – 96 66 – 90
FDg- PeT 0 – 100 50 – 100 63 – 100
Table 3: different staging techniques and their respective sensibilities, specificities and accuracies27-34
histopathological tumor characteristics
when looked at ways to predict whether a tumor will metastasize or not, whether there 
is a high or low chance at locoregional recurrence and how to estimate survival, much 
research has also been done in the field of primary tumor characteristics. If an excised 
cn0 primary SCCoC or a preoperative biopsy could be examined for several known 
prognostic characteristics, a neck dissection could for instance be performed only if 
tumorcharacteristics would indicate a high tendency to metastasize. Size (pT-stage), 
presence of perineural spread, angiolymphatic invasion, diffuse growing patterns, grade 
of differentiation and tumor depth have all been mentioned as possible prognosticators in 
predicting survival and/or locoregional recurrence9, 51-58. 
Biomarkers
Tumoral development is based on changes in normal cellular processes (like proliferation, 
differentiation, cell adhesion and apoptosis), leading to uncontrolled growth and/or 
invasion of surrounding structures and/or the ability to metastasize. The latter option 
represents a complex cascade of events, including proliferation, migration through 
interstitial cell matrices, invasion of lymph- and blood vessels, finally reaching a lymph 
node or distant organ and growing out at the new site. The assumption that characteristics 
of the primary tumor mainly determine its probability to spread metastatically, could be 
used as a predictive source of tumoral behaviour and so could possibly influence treatment 
of the neck in SCCOC. Nowadays simple light microscopy, immunohistochemistry, 
Southern blot techniques, polymerase chain reaction (PCR) and fluorescence in situ 
hybridization (FISH) are available to identify histological and genetic tumoral features. 
a biopsy-sample of the primary tumor might give the information on which treatment 
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of the neck could be based. In SCCOC and oropharyngeal SCC Roepman et al.59 
presented an independently validated primary tumor expression signature set of 102 
different predictor genes that could reliably detect the presence of metastases in regional 
lymph nodes. It performed better than current clinical staging techniques. A multicenter 
validation study is currently being performed.
conclusions
treatment of cancer of the head and neck has undergone quite some changes in the 
past century; from relative overtreatment to treatment that is more adjusted individually, 
leading to less morbidity and a higher quality of life with (slightly) improved survival. 
probably a great deal of patients suffering from SCCoC with a cn0-neck will eventually 
not be treated by a neck dissection because the percentage of occult neck metastases 
will be below 20%. However, before this point is reached, a more accurate preoperative 
staging technique will have to be found, which can be easily applied in any center for head 
and neck surgery. 
goal and outline of this thesis
goal of this thesis is to analyze the results of our current preoperative workup regarding the 
neck in cN0 SCCOC consisting of palpation and US (+/- FNAC) along with evaluation 
of postoperative results in terms of follow-up, survival and locoregional recurrence rates.
another goal is to investigate whether the percentage of occult metastatic spread found 
by postoperative histopathological examination can be lowered to less than the proposed 
20%21 by means of new preoperative imaging techniques. 
in chapter 2 we retrospectively review the treatment regime described above in 224 
patients with cN0 SCCOC, with special emphasis on the results of US (+/- FNAC) 
related to postoperative histopathological findings. 
in chapter 3 part i we prospectively analyze a group of 30 SCCoC patients with focus 
on the preoperative assessment of the cN0 neck by FDG-PET. Refinement of the used 
fdg-pet scanning technique is described in part ii.
chapter 4 describes a pilot study regarding the use of a new MRI contrast agent (USPIO) 
in 11 patients suffering from cN0 SCCOC. 
chapter 5 describes overall and disease-specific survival in 197 treated patients with cn0 
SCCoC, after 5 years of follow-up and mainly focuses on the necessity of a strict follow-
up regime.
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chapter 6 identifies histopathological tumor and neck characteristics which could have 
a prognostic value regarding recurrent disease and disease-free survival in a group of 197 
cN0 SCCOC patients.
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abstract
objective
estimating the value of our preoperative workup in the treatment of patients with 
clinically N0 (cN0) squamous cell carcinoma of the oral cavity (SCCOC).
methods
Results of preoperative palpation, ultrasound (US) and ultrasound-guided fine 
needle aspiration cytology (FNAC) were compared to the histological findings after 
unilateral or bilateral elective selective neck dissection of level I-III (SND I-III) in 
patients with cN0 SCCOC. 
results
Occult metastases were detected in 50 (22%) out of the 224 cN0 patients. No 
metastases were found beyond level III in extended neck dissections. T1N0M0 
tumors and T2N0M0 tumors metastasized in 8 out of 77 cases (10%) and 32 out of 
112 (29%) cases, respectively.
conclusions
Staging of the cN0 neck by palpation and US (+/- ultrasound-guided FNAC) missed 
occult lymph node metastases in 22% of the patients with SCCOC. The use of SND 
I-III therefore still is warranted. Frozen section sampling seemed to be redundant 
in this selected group of patients, because no additional metastases were found in 
extended neck dissection specimens. It might not be necessary to perform elective 
neck dissection in patients with T1 tumors.
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introduction
the most important prognostic factor in patients with oral cavity squamous cell carcinoma 
is the presence or absence of cervical metastases. When there was metastatic spread to 
the cervical lymphnodes, survival rates decreased by approximately 50%1-3. Until now, 
imaging techniques, such as ultrasound (US), computerized tomography (CT) and 
magnetic resonance imaging (MRI), have shown inadequate predictability of cervical 
metastases4. In contrast, minimally invasive techniques, e.g. ultrasound-guided fine 
needle aspiration cytology (ultrasound-guided FNAC), had higher sensitivity and 
specificity than the above-mentioned imaging techniques, although only in experienced 
hands5. Sentinel lymph node biopsy (SLNB) has not yet achieved the status of “standard 
of care”6; it is still considered as an experimental technique. Elective surgical procedures 
to detect potential occult metastases are currently preferable to a ‘wait and see’ policy (or 
primary radiotherapy). In the clinically node negative neck, elective surgical dissection 
forms part of the standard approach, because the risk of occult metastatic spread was 
found to exceed 20%7. The type of neck dissection used in elective surgery has changed 
over the years from radical neck dissection (as described by Crile8) to more selective 
types of neck dissection. Reasons behind these changes were greater understanding 
of regional lymph drainage patterns9 and concerns about postoperative morbidity. In 
patients with oral cavity carcinoma, selective neck dissection of level I-III (SND I-III; 
former supraomohyoid neck dissection) is the preferred technique. Besides its staging 
ability, it might also form a therapeutic option to control minimal neck disease in a 
selected group of patients10,11. However, some authors advocated the use of an extended 
neck dissection that includes level IV, or even modified radical neck dissection (MRND) 
to increase the detection rate of ‘skip metastases’12,13. In this study, we investigated the 
diagnostic and therapeutic value of the Snd i-iii after the patients had been staged 
node negative by palpation, uS and on indication, ultrasound-guided fnaC of one or 
more nodes.
materials and methods
data were available on a consecutive series of patients with histopathologically proven 
squamous cell carcinoma of the oral cavity who had been treated at the Head and neck 
Centre of the University Hospital Nijmegen between 1 January 1992 and 1 December 
2004. All the cN+ patients were excluded from the study because they had not undergone 
SND I-III. In addition, patients who had been diagnosed with any form of head and neck 
carcinoma in the previous 5 years were excluded. Patients were included if they had a 
clinically and radiologically node negative neck and had undergone Snd i-iii as part of 
their surgical treatment. Preoperative TNM staging had been performed according to the 
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system of the international union against Cancer14. Some of the patients had an indication 
for ultrasound-guided fnaC, because uS had found suspicious or enlarged lymph nodes 
(smallest axial diameter >5 mm). Unilateral SND I-III had been performed on the affected 
side, or bilateral when the tumor crossed the midline. All the operations had been carried 
out by surgeons at our Head and neck Centre, according to the procedure described by 
medina15. Suspicious nodes and/or the largest jugulodigastric and most distal jugulo-
omohyoid node were sampled and sent for frozen sectioning together with the dissection 
specimen. If frozen sectioning showed metastatic disease, SND I-III was routinely extended 
to MRND. An exception to this rule was one single metastatic node without extracapsular 
spread in level I. The neck dissection specimen was marked so that levels could be identified 
by the pathologist. Standard pathological examination of the neck dissection specimen 
consisted of Haematoxylin and eosin staining, node count with standard sectioning and 
measuring the size of the metastatic deposits in all the affected nodes. Two or more positive 
nodes in the neck dissection specimen and/or presence of extracapsular spread were 
indications for postoperative radiotherapeutic treatment of the neck.
results
The study included 224 patients with 247 SND I-III specimens. There were 145 men and 
79 women, with a mean age of 61 years at the time of surgery (range 27-90 years). The 
distributions of localisation and clinical t-staging of the tumors are shown in table 1.
Primary tumor site
(no. of  patients)
T1 T2 T3 T4 Total
Floor of  mouth 24 51 6 4 85
lateral Tongue 41 44 13 0 98
alveolar process 2 5 1 5 13
retromolar trigone 9 8 0 6 23
Buccal mucosa 1 4 0 0 5
Total 77 112 20 15 224
Table 1: Primary tumor localisations and preoperative stages (No. of patients)
all the patients had undergone ultrasound examination; in 2 patients whose tumor 
crossed the midline, only one side of the neck had been examined. Figure 1 shows 
an overview of the patients who had indications for ultrasound-guided FNAC. In 
the majority of these patients it was not possible to establish whether the cytology 
obtained during this procedure was from nodes in the same levels as those found to 
AssEssMEnT of PREoPERATIvE ulTRAsonoGRAPHy of THE nECk And ElECTIvE 
nECk dIssECTIon In PATIEnTs WITH oRAl squAMous CEll CARCInoMA
27
CHAPTER
2.0
12 pn+ 1 pn+43 pn- 6 pn-
62 ultrasound-guided fnaC
55 pn- 7 inconclusive punctures
contain metastases during histopathological examination. There was only one positive 
histopathological result out of 7 inconclusive punctures. It revealed 2 metastases: one 
in level I (0.8 x 0.7 cm) and one in level II (1.0 x 0.8 cm). The tumor deposit in the first 
positive lymph node consisted of multiple micrometastases, whereas the deposit in the 
second (level II) positive lymph node had a diameter of 1.2 mm. Thus, initial ultrasound-
guided fnaC was false-negative in 22%, while inconclusive node puncture was positive 
on histopathological examination in 14%.
Figure 1: results of ultrasound-guided fnaC
a total of 224 patients had undergone 247 Snd i-iiis: 96 on the right side, 105 on 
the left side and 23 bilateral. Figure 2 shows an overview of the surgical procedures, 
including extensions to MRND and the histopathological findings.
in 6 out of the 24 frozen section-positive necks, not only the frozen section node was 
positive: 5 necks also contained 2 levels with one metastatic node, while 1 neck also 
contained 3 levels with single metastatic nodes. In six cases, the dissections had not 
been extended to mrnd, because metastatic spread was only found in level i and 
frozen section in lower level nodes was negative. Three dissections (frozen section-
negative) had also been extended to MRND owing to strong perioperative suspicion 
of metastatic spread. Also, two bilateral SND I-IIIs had been modified to unilateral 
MRND and contralateral SND I-III due to strong perioperative suspicion of metastases. 
Histopathological examination revealed metastases on the mrnd side in these latter 
patients, although frozen section had been negative. A total of 23 SND I-IIIs had thus 
been extended (9% of necks) to MRND. Metastases were not found outside levels I-III in 
any of these extended neck dissections.
CHAPTER 2
28
Figure 2: Neck dissections (N = 224) and the pN-status
Histopathological proof of metastatic squamous cell carcinoma in one or more lymph 
nodes was found in 50 of the specimens (22%); thus, 24 out of 50 (48%) positive specimens 
had been identified correctly by frozen section sampling. MRND had been performed 
on 20 of the 50 pN+ necks and 14 of them had also received postoperative radiotherapy. 
Based on the histopathological findings, 25 of the remaining 30 pN+ patients had received 
postoperative radiotherapy.
In the 50 positive specimens levels I, II and III had been affected in 23 (46%), 31 (62%) and 
11 (22%) necks, respectively. When level III had been the only pN+ level, postoperative 
radiotherapy was administered. Positive specimens had been revealed in 8 out of the 21 
bilateral SND I-IIIs. All but one had comprised a single node in a single level on one side 
(5 in level I, 2 in II, 1 in III). The remaining specimen had been positive bilaterally, with 2 
positive nodes on the left side of the MRND specimen (levels I and II) and 1 positive node 
on the right side (SND I-III). Primary tumor localisations and T-stages in relation with the 
affected neck levels are shown in tables 2 and 3, respectively.
Primary tumor site
(no. of  positive neck 
specimens)
level(s) affected
i ii iii i + ii i + iii ii + iii i-iii
% occult
metastases
Floor of  mouth 10 5 3 2* 1 0 0 25 
lateral tongue 1 11 2 3 0 2 1 20
alveolar process 1 1 0 2 1 0 0 38
retromolar trigone 0 2 0 1 0 1 0 17
Buccal mucosa 0 0 0 0 0 0 0 0
Table 2: Tumor localisations and the affected lymph node levels in 50 positive neck specimens (* = positive 
bilateral neck dissection)
18 mrnd
18 pn+
2 pn+
5 mrnd
6 no mrnd
4 pn+
18 pn+ 137 pn-
155 no mrnd
8 pn+24 frozen section pn+ 160 frozen section pn- 32 pn-
224 patients
184 frozen section sampling 40 no frozen section sampling
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TN-classification
(no. of  patients)
level(s) affected
i ii iii i + ii i + iii ii + iii i-iii
% occult
metastases
 T1 1 6 0 1 0 0 0 10
 T2 8 11 5 3 1 3 1 29
 T3 2 1 0 2 0 0 0 25
 T4 1 1 0 2* 1 0 0 33
Total 12 19 5 8 2 3 1 22
 
Table 3: Tumor stages and the affected lymph node levels in 224 patients (* = positive bilateral neck 
dissection)
 
Tables 4 and 5 show the numbers of occult metastases in the patients with t1 and t2 
tumors, respectively. In T1 oral cavity tumors the risk of occult metastases was about 
10% (8 out of 77 T1 tumors). In T2 tumors the risk increased to about 30% (32 out of 112 
T2 tumors). Tumor-positive nodes were subdivided into three groups according to the 
smallest diameter of the metastatic deposit inside the lymph node: 0-5 mm, 6-10 mm and 
>10 mm. These dimensions had been recorded in only 44 pN+ necks. 
Tumor localisation 
(no. of  patients)
 neck status
 pn0  pn+  % pn+ 
Floor of  mouth  22  2  8%
lateral tongue  36  5  12%
retromolar trigone  8  1  11%
alveolar process  2  0  0%
Buccal mucosa  1  0  0%
Table 4: t1n0m0 tumors and the histopathological neck status
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Tumor localisation 
(no. of  patients)
 neck status
 pn0  pn+  % pn+ 
Floor of  mouth  35  16  31%
lateral tongue  32  12  27%
retromolar trigone  5  3  38%
alveolar process  3  2  40%
Buccal mucosa  4  0  0%
Table 5: t2n0m0 tumors and the histopathological neck status
Tables 6 and 7 show these subgroups in relation with the clinical t-stage and the 
localisation of the primary tumor, respectively.
TN classification tumor 
(no. of  specimens)
smallest diameter of  metastatic deposit
 0-5 mm  6-10 mm  >10 mm 
 T1  5 (63%)  2 (25%)  1 (12%)
 T2  22 (81%)  5 (19%)  0
 T3  3 (60%)  2 (40%)  0
 T4  4 (100%)  0  0
Total  34 (77%)  9 (20%)  1 (23%)
Table 6: tumor stages and size of the metastatic part in the lymph nodes
Tumor localisation 
(no. of  specimens)
smallest diameter of  metastatic deposit
 0-5 mm  6-10 mm  >10 mm 
Floor of  the mouth  18 (86%)  3 (14%)  0
lateral side of  oral tongue  12 (71%)  5 (29%)  0
retromolar trigone  2 (67%)  0  1 (33%)
alveolar process  2 (67%)  1 (33%)  0
Total  34 (77%)  9 (20%)  1 (2%)
Table 7: tumor localisation and size of the metastatic part in the lymph nodes
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Discussion
an earlier study at our centre16 showed that Snd i-iii with frozen section sampling 
was a useful tool to manage the cn0 neck in patients with primary squamous cell 
carcinoma of the oral cavity. In the present study, US of the neck (+/- ultrasound-guided 
FNAC) had been added to the standard preoperative evaluation protocol. Our group 
of 224 patients with cn0 oral cavity squamous cell carcinoma had all undergone Snd 
I-III. The addition of ultrasonographic evaluation of the neck led to reductions in the 
percentage of missed occult metastatic lymph nodes from 31% in our initial study to 
22%, or even to 20% when the focus was on individual necks.
There was a significant difference (p=0.016) in the risk of developing occult metastases
between T1 (10%) and the other T-stages (T2 = 29% T3 = 25% and T4 = 33%). Tumor 
localisation seemed to have less influence.
after ultrasonographic evaluation of the neck, Snd i-iii found occult metastatic lymph 
nodes in 22% of the patients (50 out of the 224). This rate was more favourable than that 
reported in a number of studies9,17 that evaluated the neck with palpation or Ct/mri, but 
without US. US (+/- FNAC) has the highest reported sensitivity, specificity and accuracy 
to evaluate the n0 neck,18,19 but this strategy has not yet been adopted widely.20-24 in 
our patients with T1 oral cavity squamous cell carcinoma, the 10% (8 out of 77) risk of 
having occult lymph node metastases was well below the 20% cutoff point for elective 
surgical treatment of the cN0 neck, as proposed by Weiss et al.7 Based on these findings 
alone there seems no indication to perform Snd i-iii on patients whose uS stage is 
ct1n0m0; of course, factors such as pernineural invasion, tumor depth and disease-
specific survival should be taken into account as well before strong recommendations can 
be made. Future research will be focused on these specific characteristics. Contrastingly, 
the 29% (32 out of 112) risk in cT2N0M0 patients obviously demands elective surgical 
treatment of the neck, as do the 25% (5 out of 20) risk in T3 patients and the 33% (5 out 
of 15) risk in T4 patients.
perioperative frozen section sampling had been performed in the majority of cases 
(184 out of the 224 patients: 75%), even in the absence of suspicious nodes. In this way, 
almost half of the necks that contained occult metastases (24 of 50) had been identified 
perioperatively. Neck dissection had been extended in 24 patients, mostly because frozen 
section sampling had revealed tumor-positive lymph nodes. In this additional part of 
each neck dissection specimen (levels IV and V) not a single metastatic node was found. 
there is an indication for postoperative radiotherapy when there are multiple lymph 
node metastases, or when there is extracapsular spread and probably also when only 
level III is affected (in this study: 2%, i.e. 5 out of the 224 patients). Several authors 
mentioned the importance of ‘skip metastases’. Byers et al.12 defined skip metastases as 
tumor-positive lymph nodes in level III or IV, while levels I and II were unaffected. They 
reported an incidence of 15.8%. When focused on the cN0 necks with histopathologically 
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proven metastasic spread to level IV only, 5 out of the 34 patients remained. Thus, 
frequency of skip metastases solely to level IV was 2%. Percentages of sole metastases 
in level IV were also low in the studies by Crean et al.13 and Shah et al.9: 4% and 1.5%, 
respectively. Preoperative US evaluation of the neck had not been used in two of the 
studies, but if it had, some of the metastases might have been found, which would have 
lowered these percentages even further. When US evaluation revealed cT2-4N0 oral 
cavity squamous cell carcinoma, standard Snd i-iii with sampling of levels i, ii and 
III appeared to focus on the appropriate levels at risk. There were no indications to 
include level IV. Routine perioperative frozen section sampling was not indicated either, 
because a single tumor-positive node in level i or level ii did not seem to justify extension 
of the neck dissection to MRND. When histopathological evaluation revealed multiple 
metastases or extracapsular spread, postoperative radiotherapy was indicated, in line 
with the dutch guideline25 and the international standards. 
when we considered the size of the metastatic deposits in the 44 documented pn+ necks, 
77% (n=34) fell into the smallest diameter category of 0-5 mm. Therefore, we believe 
that our preoperative approach consisting of palpation and US (+/- FNAC) represents 
the upper accuracy limits of the currently available minimally invasive preoperative 
staging techniques. Recently, sentinel lymph node biopsy (SLNB) and fluoro-deoxy-
glucose positron emission tomography (FDG-PET) have been introduced as diagnostic 
options to reduce the risk of occult metastases to less than 20%. Most of the SLNB 
research consisted of pilot studies in which fairly promising results were found. Paleri 
et al.26 conducted a meta-analysis on 19 articles that evaluated the use of SlnB in oral 
and oropharyngeal cancer. They concluded that although none of these pilot studies 
were blinded, SlnB showed high sensitivity in oral and oropharyngeal squamous cell 
carcinoma and the results were reliable and reproducible. However, the localisation of 
the lymph nodes played an important role: nodes in level I were more difficult to examine 
by uS and SlnB than nodes in other levels6,27. When we addressed this issue in our 50 
pN+ necks, we found sole tumor-positive nodes in level I in 13 cases (26%). One of the 
metastatic deposits had a smallest diameter of 6-10 mm, whereas all the other 12 deposits 
fell into the 0-5 mm category (92% of the metastases in level I). Especially the floor of 
mouth tumors had a tendency to affect level I (10 out of 21; 48%). These findings imply 
that the ultimate preoperative technique will have to be able to detect micrometastatic 
deposits and correctly stage the lymph nodes in level I. 
No consensus has been reached about the use of FDG-PET to stage the cN0-neck. A 
former study conducted at our centre28 showed that fdg-pet had remarkably low 
sensitivity in patients whose neck had been staged cN0 by palpation and US (+/- FNAC). 
this was in line with the results of other studies after correction for the preoperative neck 
status. The sizes of the metastatic deposits in the current study were comparable with those 
in our former study. Therefore, 77% of the metastases would have been hard to diagnose 
with FDG-PET, because their smallest diameter was less than 5 mm. This indicates 
AssEssMEnT of PREoPERATIvE ulTRAsonoGRAPHy of THE nECk And ElECTIvE 
nECk dIssECTIon In PATIEnTs WITH oRAl squAMous CEll CARCInoMA
33
CHAPTER
2.0
that fdg-pet is unlikely to play a future role in the preoperative detection of occult 
metastatic deposits. Level I nodes would be especially difficult to display and diagnose, due 
to overprojection of the primary tumor. 
at present histopathological staging of the neck seems to be superior to any type of 
noninvasive preoperative staging technique. However, promising results have recently 
been published on the detection of micrometastases in prostate cancer using new mri 
contrast agents (ultrasmall super-paramagnetic iron oxide [uSpio])29. Until now, very 
few results are available in patients with head and neck squamous cell carcinoma, but the 
approach seems promising with a sensitivity of 86-96% and a specificity of 77-100%30-32. 
to our knowledge, no studies have been published on oral cavity squamous cell carcinoma 
alone. At our centre, we are currently conducting a prospective pilot study on USPIO in 
patients with cN0 squamous cell carcinoma of the oral cavity.
conclusions
in patients with cn0 squamous cell carcinoma of the oral cavity, the occult metastatic 
rate was 22% (50 out of the 224 patients) after a combination of palpation and US 
+/- ultrasound guided FNAC had been used to stage the neck. In the patients with 
cT1N0M0, the occult metastic rate was 10% (8 out of the 77 T1 patients), so routine 
SND I-III might not be necessary. 
Selective neck dissection of level i-iii remains the elective neck dissection of choice in 
cT2-4N0 cases. When frozen section sampling is tumor-positive, it does not seem to be 
necessary to extend routine perioperative frozen section sampling or neck dissection 
to levels IV and V, because no metastases were found beyond level III. Therefore the 
indications for routine perioperative frozen section sampling are limited.
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abstract
objective
With improved diagnostic imaging techniques it remains difficult to reduce occult 
metastatic disease in squamous cell carcinoma of the oral cavity (SCCOC) to less 
than 20%. Therefore supraomohyoid neck dissection (SOHND) still is a valuable 
staging procedure in these patients.
this study was conducted to see whether adding fdg-pet to routine preoperative 
workup could reduce the incidence of occult metastasis. 
methods
patients with clinically and ultrasonographically staged cn0 SCC of the oral cavity 
underwent FDG-PET prior to SOHND. Histologic examination of neck dissection 
specimens was used as a ‘gold standard’.
results
Twenty-eight consecutive patients were included, representing 30 necks. Occult 
metastatic disease was found in 30% of SOHND specimens. Average diameter of 
metastatic deposits was 4.3 mm. Sensitivity, specificity and accuracy of FDG-PET 
was 33%, 76% and 63% respectively. 
conclusions
in patients with cn0 SCC of the oral cavity fdg-pet does not contribute to the 
preoperative work-up. FDG-PET does not replace SOHND as a staging procedure.
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introduction
the oral cavity is one of the cancer sites in the the head and neck accompanied by a high 
incidence of occult regional metastasis. As the presence of cervical lymph node metastasis 
significantly reduces survival, this important prognostic factor remains an issue for scientific 
debate. In these discussions the changing necessity, diagnostic value and therapeutic role of a 
selective neck dissection of levels I-III, also called supraomohyoid neck dissection (SOHND), 
is often addressed.
in 1980, Hanley1 summarizes the opinion at that time about SoHnd as a well-recognized, 
although generally unaccepted form of treatment in oral cavity cancer patients. He compared 
the SoHnd to the standard radical neck dissection in 62 patients with oral cavity tumors 
and found “similar and no worse results for the SOHND”. He felt that less than radical neck 
dissection required further exploration. Since then the opinion about SOHND has gradually 
changed2. The SOHND has been popularized over the years and has become a generally 
accepted staging procedure for the clinically negative neck in oral cancer patients3,4. In cases 
of limited nodal disease on histopathological examination some consider it therapeutic5. 
Several studies have shown that even with improved diagnostic imaging techniques it still 
remains difficult to reduce occult metastatic disease in oral cavity cancer to less than in 20% 
of the patients3,4. The 20% threshold is considered important as elective treatment of the neck 
remains indicated when the probability of occult neck metastases exceeds 20%6. 
Palpation of the neck, with a sensitivity and specificity of 60-80%, is not a very accurate way 
to search for cervical metastases. Computed tomography (CT), magnetic resonance imaging 
(MRI), ultrasonography (US), sentinel lymph node biopsy (SLNB) and ultrasound-guided 
fine needle aspiration cytology (USgFNAC) have shown to be superior to palpation, with 
the latter being the most accurate way of investigation. However in patients with a clinically 
negative neck even uSgfnaC is reported to have a sensitivity of no more than 48-76%, most 
likely explained by the limited tumorload7,8. USgFNAC of the sentinel node does not seem to 
increase sensitivity9. With these results in mind the risk of occult metastatic disease remains 
between 15-25%9,10.
Positron emission tomography (PET) with fluorodeoxyglucose (FDG) is increasingly used in 
preoperative staging of cancer patients. FDG depicts the increased metabolism of malignant 
cells as compared to normal cells. Reports on the value of FDG-PET in detecting occult 
metastatic disease have been contradictionary with a reported sensitivity ranging from 
0-100% and specificity from 92-100%11-13. The added value of FDG-PET to the clinical 
and ultrasonographical evaluation of the neck in oral carcinoma has not been properly 
investigated. We conducted a study in order to evaluate whether further reduction of occult 
metastatic disease in oral carcinoma can be achieved by adding fdg-pet scanning to 
the preoperative work-up. With 21% reported occult metastatic disease in oral carcinoma 
after a negative ultrasonographic investigation in our hospital10 this could implicate that a 
diagnostic SOHND would no longer be indicated.
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materials and methods
Patients
this prospective study was performed at the radboud university nijmegen medical 
Centre between June 2001 and December 2003. All patients planned for SOHND as 
part of the treatment for a clinically N0 (cN0) squamous cell carcinoma (SCC) of the 
oral cavity were included in the study and offered a FDG-PET-scan. Prior to inclusion 
all patients were clinically staged N0. A cN0 neck is defined as a neck staged N0 by 
preoperative palpation by an experienced ent- surgeon, oral and maxillofacial surgeon 
and radiotherapist and a standard preoperative uS performed with uSgfnaC on 
indication. FNAC of enlarged lymphnodes was performed in nodes with a diameter >0.5 
cm. In case of a cN+ neck, the patient was offered a modified radical neck dissection 
(MRND) and was excluded from the study.
The study was approved by the local Medical Ethics Committee. Informed consent was 
obtained from all patients. No patient suffered from cancer within 5 years prior to this 
study nor was previously treated by radiotherapy or chemotherapy. 
FDG-PET
A dedicated PET-scanner (ECAT-EXACT, Siemens/CTI, Knoxville, TN, USA) was 
used for data acquisition. Prior to FDG-injection, patients were fasting for at least 6 
hours. Intake of sugar-free liquids was permitted. Immediately prior to the procedure, 
the patients were hydrated with 500 ml of water. One hour after intravenous injection 
of 220-250 MBq FDG (Mallinckrodt Medical, Petten, The Netherlands) and 20 
mg furosemide, emission and transmission images of the head and neck area were 
acquired (2-3 bedpositions, 10 minutes per bedposition). The images were corrected 
for attenuation and reconstructed using the ordered-subsets expectation maximization 
(OSEM) algorithm. The reconstructed images were displayed in coronal, transverse and 
sagittal planes and evaluated by three nuclear medicine physicians.
The mean glucose level just before PET-imaging was 5.3 mmol/L; three patients had 
diabetes mellitus (glucose levels 10.3, 6.8 and 3.4 mmol/L). 
For statistical analysis the sensitivity, specificity and accuracy of FDG-PET were 
calculated.
Surgical Technique and Pathologic Examination
SoHnd was performed as described by medina et al2. In case of enlarged or suspicious 
nodes found during surgery, frozen stage section (FSS) analysis was performed. If 
positive, the neck dissection was extended to a MRND. The neck dissection specimen 
was marked anatomically by the surgeon (a senior staff-member of the department of 
otorhinolaryngology and Head & neck Surgery or of the department of oral and 
Maxillofacial Surgery) and sent for pathologic examination consisting of node count, 
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evaluation of malignancy in any of the nodes and extracapsular spread. Standard 
sectioning and HE-staining was performed on all lymph nodes. Lymph node metastases 
were defined as micrometastasis when a metastatic deposit had a largest diameter of less 
then 4 mm.
results
Thirty patients (15 male, 15 female; median age 60 years, range 32 - 84 years) were 
enrolled. One FDG-PET-scan was unevaluable due to significant movement of the 
(diabetic) patient during imaging. One patient had a SOHND 49 days after FDG-PET 
and was also excluded. Twenty-eight scans could be evaluated (15 women, 13 men), 
representing 30 SOHNDs. Site of the primary tumor and T-stage are shown in table 1. 
n T1 T2 T3 T4
Floor of  the mouth 9 3 4 1* 1*
Tongue 17 6 8 3 0
alveolar Proces 2 0 1 0 1
Table 1: localizations and clinical t-stage of the 28 tumors
 * = medial floor of the mouth
none of the patients had any sign of metastatic spread based on clinical examination 
and US of the neck. In 8 patients, US was supplemented with USgFNAC, which resulted 
in negative cytology. Additionally, 4 patients had a CT of the head and neck, all without 
suspect nodes. In 26 patients (28 necks) FSS of the neck specimen was performed: 25 
(89%) necks were negative and 3 (11%) were positive. All 3 necks positive on FSS turned 
out to be true-positive and one of 25 negative fSS specimens turned false negative during 
further pathologic investigation. In the 3 necks (10% of necks) with a positive FSS of the 
SOHND-specimen, the SOHND was extended to a MRND. No additional metastatic 
nodes were found in levels IV and V. A total number of 555 nodes was examined in 
28 patients. The total number of nodes found in regions I to III varied from 11 to 38. 
Nine out of 30 necks (30%) contained occult metastases in a total of 16 lymphnodes; no 
bilateral metastases were found. 
The average diameter of the metastatic deposit was 4.3 mm (range 0.5 mm to 8.0 mm). 
five of the malignant nodes showed signs of extracapsular spread, being a prognostic 
factor of enhanced metastatic spread3. An overview of the patients and their nodes, is 
presented in table 2 (addendum). 
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usgFnac
Three of 8 patients (38%; 3 of 9 punctured necks: 33%) in whom USgFNAC was negative, 
did have lymph node metastases at pathological examination of the SoHnd specimen: 
in one case a node in the punctured level was positive; the other two patients had one 
and two positive nodes in non-punctured levels. In patients in whom no USgFNAC was 
performed, 6 of 21 SoHnd specimens proved to be positive for lymph node metastases 
(29%).
FDg-PeT
In 1 patient (3,6%) the FDG-PET-scan showed no sign of the primary tumor as this tumor 
(tongue) was already removed by a radical excision biopsy in a secondary referral center. 
The other 27 primary tumorsites were correctly depicted. This leads to a sensitivity of 
100% for visualizing the primary tumor. 
In 8 cases (29%) FDG-PET showed ipsilateral hot-spots suspect for possible metastases; 
20 scans representing 22 necks were negative. Patients were on average surgically 
treated within 14 days (1-30, median 12 days) after receiving their PET-scan. Twenty-
eight patients underwent 30 neck dissections (2 bilateral, due to a floor of the mouth 
tumor crossing the midline).
FDG-PET correctly recognized 3 out of 9 (33%) afterwards pathologically proven 
positive necks; these positive nodes were found in the correctly depicted level, although 
one patient had 7 positive nodes divided among levels I and II. His PET-scan only 
showed 3 positive spots in level II. In 5 patients FDG-PET showed a suspect node which 
was not confirmed by pathologic examination; in one of these cases USgFNAC was 
performed 3 weeks prior to FDG-PET. FDG-PET also failed to show any positive nodes 
in 6 patients whilst pathologically present, leading to a sensitivity and specificity of 33% 
and 76% respectively for 30 necks. Accuracy reached 63% for FDG-PET. If SOHND 
would only be performed when fdg-pet was positive for lymph nodes, the number of 
SOHNDs would have been reduced by 73% (from 30 to 8). However, this algorythm 
would result in 6 out of 30 necks with unrecognized occult metastases (20%).
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Discussion
Supraomohyoid neck dissection has shown to be a valid staging procedure in cn0 oral SCC3. 
CT, MRI and US lack sensitivity and specificity for diagnosing occult metastatic disease as 
micrometastases can occur in the absence of morphologic changes in lymph nodes, while 
these changes can be both reactive and metastatic. That is the main reason why USgFNAC 
is considered to be superior to these imaging modalities, especially when normal-sized and 
thus non-suspicious nodes in the first echelons are punctured. As the majority of patients 
in this study did not receive fnaC, this might explain why the 30% of necks with occult 
metastatic nodes in this study was higher than the initially reported 21%10 from our institute. 
All metastases in the SOHND-specimens were located in the first echelons. As the metastatic 
parts of the affected nodes were very small, morphologic changes were unlikely to appear in 
the majority. Furthermore, CT-scanning of the head and neck is no standard preoperative 
staging technique in patients with a cn0-neck in oral SCC according to the national dutch 
guideline on diagnosis and treatment of oral and oropharyngeal cancer. 
Several studies have shown that it is possible to reduce occult metastatic disease in oral SCC 
to approximately 20%5,10. As a 20% false-negative rate is considered to be the limit for a wait 
and see policy versus elective treatment of the neck6, clinicians are expected to be divided 
into two groups advocating either one of these treatment strategies. Many surgeons feel that 
the morbidity of a SoHnd is acceptably low and outweighs the risk of being confronted 
with advanced neck disease after a wait and see or wait and scan policy14. Nevertheless, if 
a diagnostic strategy would further reduce the rate of occult metastasis, SoHnd could be 
abandoned. Recent studies have mainly focused on sentinel node biopsy and FDG-PET 
scanning of the neck. 
SlnB might possibly identify those patients that harbour occult metastatic disease in cn0 
oral SCC. Ross et al.15 describe the preliminary results of a multicenter trial in patients 
with T1-2N0 oral cavity/oropharynx carcinoma. In 93% of 134 cases a sentinel node 
could be identified. In 55 cases SLNB was combined with an elective neck dissection. 
Occult metastatic disease was present in 34%. Sensitivity of this technique was reported 
to be 93% in all oral SCC. In floor of the mouth SCC only however identification of the 
SLN was possible in 86% (n=43) and sensitivity reached 80%. Beside selection of patients 
for (additional) neck surgery, histopathologic evaluation of the sentinel node might limit 
cost and time consuming pathological evaluation by performing step serial sectioning 
and immunohistochemistry of the sentinel nodes which are most suspected to harbour 
metastases.
However, skip metastases might prove to be a problem16. Difficulties identifying level I 
sentinel lymph nodes in oral SCC have been reported15. In our series, 31% of the metastatic 
nodes were located in level I. Thus, questions wether SLNB offers a significant advantage 
over SOHND still remain. Unresolved issues regarding this technique are the feasability of 
and efficacy in multiple level sentinel nodes and the cost-effectiveness. 
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furthermore, underestimation of occult metastatic disease with standard sectioning and 
He staining is likely to be present in about 8%17,18. It is unclear if these micrometastases 
need more than a SoHnd or if SoHnd can be considered adequate treatment in these 
cases. Potential overtreatment of such limited disease with a MRND needs to be subject 
of clinical studies as stated by Pitman et al. in a review on SLNB in head and neck 
cancer19. Nieuwenhuis et al.9 investigated the role of uSgfnaC of the sentinel node in 
cT1-2N0 oral/oropharyngeal carcinoma. Although the sentinel node could be identified 
and aspirated in 38 out of 39 patients, it did not decrease false negative rate compared 
to USgFNAC alone. The additional value of sentinel node cytology was thus questioned. 
Considerable attention has been paid to fdg-pet in the evaluation of the n0 neck in 
head and neck cancer. In our study we have included only patients without evidence 
of metastatic neck disease in preoperative evaluation consisting of at least palpation 
and US and who were thus scheduled for a surgical treatment including a SOHND. 
Sensitivity in this selected patient group is insufficient to refrain from SOHND on the 
basis of FDG-PET.
In FDG-PET studies specifically addressing oral cavity or oropharyngeal cancer patients 
with a cN0 neck huge variations in sensitivity (from 0 to 100%) are reported11-13, 20. Brouwer 
et al.11 showed that in the studies using routine histopathological work-up11,12 a much 
higher sensitivity (67%-100%) for the detection of occult lymph node metastases was 
found in comparison to the studies in which step sectioning and immunohistochemistry 
as part of the sentinel node procedure was performed. In the latter studies a sensitivity of 
only 0-40% was found13,20. They point out that the histopathological method used seems 
to be the most important factor for the differences in sensitivity. However, we feel that 
patient selection and differences in inclusion criteria are other major reasons for these 
differences. In the “less sensitive studies” only patients were included who were clinically 
as well as ultrasonographically N0 and in the “sensitive studies” patients were included 
that had a clinically negative neck but often had radiological evidence of metastatic 
disease12-14,20. If the results of the studies in table 3 are combined, while excluding 
patients with radiological evidence of metastases, overall sensitivity drops from 38% to 
25% (84 patients, 92 necks). This is in line of the diagnostic yield of FDG-PET in our 
study of patients with lymph node metastases all smaller than 8 mm. 
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study
# 
patients 
in study
# patients 
palpably 
n0
# patients 
palpably and 
radiographically 
n0 
   Pat.         necks
Pathology
 sensitivity 
PeT in 
study
 Specificity 
PeT in 
study
 accuracy 
PeT in 
study
myers 
et al.12
1998
14 14    8              12 ? 78% 100% 92%
civantos
et al.20
2001
18 18    18            18? iHSn† 30% 100% 61%
hyde
et al.13
2003
19 18    18            20 iHSn 0% 100% 78%
Brouwer 
et al.11 
2003
15 15    12            12 He 67% 92% 87%
Wensing
et al.
2005
28 28    28            30 He 33% 76% 63%
Total 94 93    84            92 - 38% 92% 74%
Corrected data for 84 patients palpably and radiographically n0 25%‡ 91% 72%
Table 3: Comparison of studies considering the use of FDG-PET to find metastatic spread in patients 
suffering from head and neck carcinoma (laryngeal and hypopharyngeal cancer excluded) regarding the 
clinically N0-neck. 
* HE = Haematoxylin Eosin staining 
 ? = could not be retrieved from study 
† IHSN = ImmunoHistochemistry of Sentinel Node only 
‡ corrected percentages are based on number of treated necks (108 – 4 of Braams et al. since no sensitivity 
could be estimated in the 2 remaining patients) 
conclusions
in conclusion, fdg-pet does not lower the false-negative rate of occult lymph node 
metastases in patients with an oral SCC and a clinically and uS negative neck below 
the clinically required 20% of patients. Therefore, FDG-PET has no added value in the 
preoperative work-up. FDG-PET alone or in combination with US (+/- FNAC) cannot 
replace SOHND as a staging procedure.
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Pt-# age m/F cT-stage us / Fnac FDg-PeT PaTh†
Diameter of  
metastatic deposit
1 76 f t4 neg / np* neg neg -
2 79 f t2 neg / neg neg neg -
3 55 f t1 neg / np neg neg -
4 a 55 f t4 neg / neg neg neg -
4 b 55 f t4 neg / neg neg neg  -
5 71 f t2 neg / np neg neg  -
6 58 f t2 neg / np neg 1 in i 2 mm
7 55 m t2 neg / neg pos, 2 in ii neg -
8 30 m t2 neg / np pos, 1 in ii neg -
9 66 f t1 neg / np neg neg -
10 77 f t2 neg / np neg neg -
11 79 m t2 neg / np neg neg -
12 47 m t1 neg / np neg 1 in i 5 mm
13 58 f t3 neg / np neg neg -
14 82 f t2 neg / np pos, 1 in ii 1 in ii 1 mm
15 53 m t1 neg / neg neg 1 in i 2 mm
16 52 m t3 neg / np pos, 1 in ii neg -
17 44 f t2 neg / neg neg 2 in ii 4 and 2 mm 
18 50 m t1 neg / np pos, 1 in ii 1 in ii 7 mm 
19 64 m t1 neg / neg neg neg - 
20 71 f t2 neg / np pos, 1 in ii neg -
21 45 m t1 neg / neg neg neg -
22 59 f t2 neg / np pos, 2 in ii neg -
23 47 m t1 neg / np neg neg -
24 55 m t3 neg / np neg neg -
25 66 m t1 neg / np neg neg -
26 72 f t2 neg / np pos, 3 in ii 6 in ii, 1 in i 3 x 8, 7, 5, 4 & 1,2 mm
27 42 m t2 neg / neg neg 1 in ii 4 mm
28 a 70 f t3 neg / np neg 1 in i 5 mm
28 b 70 f t3 neg / np neg neg -
Table 2. Demographic, clinical, imaging and pathological characteristics of the 28 patients. All nodes were 
found on the side of the tumor. * np = not performed. † PATH = pathological examination: number of 
metastatic nodes in level
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abstract
objective
Reconstruction parameters are an important factor in PET image quality. In the 
head and neck area, where the level of photon attenuation is relatively low, standard 
whole-body reconstruction (SWR) parameters may lead to suboptimal results. 
the purpose of this study was to evaluate the impact of optimised head and neck 
reconstruction (OHR) parameters on image quality and diagnostic
accuracy, using pathology as the gold standard.
methods
SWR parameters consisted of 2 iterations, 8 subsets and a 6-mm Gaussian filter. 
predetermined oHr parameters were 4 iterations, 16 subsets and a 5-mm gaussian 
filter, generating images with increased spatial and contrast resolution but also 
with increased noise. SWR- and OHRbased FDG-PET images of 28 patients with 
malignancies in the head and neck area were evaluated for primary tumour and 
pathological lymph nodes. Diagnostic accuracy was determined by histopathological 
verification after lymph node dissection.
results
using oHr, sensitivity for detection of a primary tumour increased from 92% to 
100%. Eleven additional lymph nodes were visualised in eight patients, resulting 
in an increased sensitivity for lymph node metastases from 11% to 44%. Specificity 
decreased from 89% to 74% owing to visualisation of small reactive lymph nodes. 
In total, using OHR, FDG-PET diagnosis improved in six patients (21%) at the 
expense of three additional false positives for lymph node metastasis (11%). Primary 
tumour Suvmax increased by 42%, indicating enhanced contrast resolution.
conclusions
image reconstruction adapted to low photon attenuation in the head and neck 
area may improve image quality and the diagnostic value of fdg-pet, despite a 
slightly higher false positive rate attributable to the fact that visualisation of fdg 
accumulation in benign reactive lymph nodes is also enhanced.
oPTIMIsEd PET REConsTRuCTIon In THE HEAd And nECk AREA: 
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introduction
primary tumours in the head and neck area are often small at the time of discovery, 
especially when located in the oral cavity. Lymph node metastases tend to be small and 
multiple in number. Among patients without clinically apparent lymph node metastasis 
(staged cN0), pathological examination after lymph node dissection shows occult metastases 
in up to 40%1. Accurate staging of the primary tumour and lymph nodes is essential for 
determination of prognosis and appropriate selection of therapeutic strategies. 
Positron emission tomography with 18F-fluorodeoxyglucose (FDG-PET) provides high 
contrast resolution and high sensitivity for the detection and staging of a wide variety 
of malignant diseases. In the head and neck area, some authors have reported a high 
accuracy of fdg-pet for the detection of primary tumours and lymph node metastases2-5. 
However, others have reported a low sensitivity for the detection of lymph node metastases, 
especially micrometastases6. 
a major drawback of fdg-pet is its relatively limited image quality, expressed in a low 
spatial resolution and a tendency to produce noisy images. In PET scanning, image quality 
can be influenced by parameters such as injected dose, acquisition mode and acquisition 
times. Furthermore, it is reduced by physical limitations, such as annihilation photon non-
collinearity, off-axis detector penetration, Compton scatter and positron range in tissue7, 8. 
Patient motion may also play a role in adversely affecting image quality. 
an additional important factor that impacts on image quality is the image reconstruction 
procedure. The choice of an image reconstruction algorithm and its parameters affect 
contrast resolution, spatial resolution and level of noise. All three factors influence the 
measured standardised uptake values (SUVs) and clinical reporting9. Optimum values 
depend mainly on scanner characteristics and the level of attenuation. Specifically in the 
head and neck area, attenuation is much lower as compared to the central body. This 
results in better count statistics and lower noise levels by default. Less filtering is needed and 
more iterations may be used without creating unacceptable noise. Standard whole-body 
reconstruction (SWR) parameters, however, are optimised for the patient as a whole, and 
disregard particular issues relating to specific body parts such as the head and neck area.
The actual diagnostic benefit of optimised reconstruction algorithms for the head and 
neck area remains unconfirmed. The aim of this study was to assess the impact of better 
image quality from optimised head and neck reconstruction (OHR) images on diagnostic 
yield in the staging of malignancies in the head and neck area.
materials and methods
twenty-eight patients with newly diagnosed malignancies in the oral cavity were 
included (table 1). None of the patients had clinical signs of lymph node metastases, 
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and none had evidence of lymph node metastases on ultrasonographic evaluation of the 
neck, including fine-needle aspiration of visible lymph nodes when appropriate. None of 
the patients had a history of diabetes mellitus, and fasting glucose levels were within the 
normal range.
Patients Tumour characteristics at pathology
no. sex age Tumour location Primary tumor stage
1 f 76 left side of  the tongue T4
2 f 79 right side of  the tongue T2
3 f 55 Right floor of  the mouth T1
4 f 55 Ventral floor of  the mouth T4
5 f 71 Right floor of  the mouth T2
6 f 58 Ventral floor of  the mouth T2
7 m 55 Right floor of  the mouth T2
8 m 30 left side of  the tongue T2
9 f 66 left side of  the tongue T1
10 f 77 left side of  the tongue T2
11 m 79 Ventral floor of  the mouth T2
12 m 47 Ventral floor of  the mouth T1
13 f 58 left side of  the tongue T3
14 f 82 right side of  the tongue T2
15 m 53 right side of  the tongue T1
16 m 52 right side of  the tongue T3
17 m 20 right side of  the tongue T1
18 m 64 Ventral floor of  the mouth T1
19 f 71 left side of  the tongue T2
20 m 45 left side of  the tongue T1
21 f 59 right side of  the tongue T2
22 m 47 right side of  the tongue T1
23 m 55 left side of  the tongue T3
24 m 66 Left side of  the tongue (EB) T1
25 f 72 left retromolar trigone T2
26 m 79 right side of  the tongue T3
27 m 42 right side of  the tongue T2
28 f 70 right side of  the tongue T3
avg 61
 
 Table 1: Characteristics of patients included in the study 
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FDG-PET
All PET scans were acquired using a full-ring dedicated PET scanner (Siemens ECAT 
Exact 47, Siemens AG, Germany), with a voxel size of 5.15 mm in all directions. One 
hour after injection of 250 MBq FDG (Tyco-Mallinckrodt, Petten, The Netherlands), 
emission images were acquired in 3D mode. GE-based transmission imaging was 
performed for attenuation correction. Acquisition time per bed position was 5 min for 
emission and 3 min for transmission.
 
Image reconstruction
all pet scans were reconstructed using an iterative 2d ordered subset expectation 
maximisation (OSEM) algorithm10. For SWR, parameters were left unchanged for 
normal whole-body imaging (i.e. 2 iterations, 8 subsets and a three-dimensional 
Gaussian filter of 6 mm). Attenuation correction was based on segmented transmission 
images. Average reconstruction processing time for a whole body study was 3 minutes.
in addition, the head and neck area was reconstructed a second time using the oHr 
parameters. These parameters were determined beforehand, by three observers who 
reached a consensus in visual analysis of multiple reconstructions. The best results 
in respect of spatial resolution, contrast resolution, noise level, blurring and observer 
confidence were achieved on our system when using 4 iterations, 16 subsets and a 
three-dimensional Gaussian filter of 5 mm. Attenuation correction was based on non-
segmented transmission images. With these settings, the average calculation time for 
two bed positions was 10 min. Examples of FDG-PET scans of the head and neck area 
generated with different reconstruction parameters are shown in figure 1. In contrast, 
these values were clearly not suitable for the central body, as illustrated in figure 2.
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Figure 1: Effects of different reconstruction parameters on image quality. From left to right, reconstructions 
with a an increasing number of iterations, using fixed subsets (16) and no filter; b an increasing number of 
subsets, with fixed iterations (4) and no filter; and c an increasing Gaussian filter size, with fixed iterations (4) 
and subsets (16). Note the changes in visibility of the small lymph node in the dorsal nasopharyngeal wall, as 
well as better contour detection of the primary tumour
Figure 2: the effects of reconstruction optimised for low attenuation levels on image quality in more 
attenuated parts of the body. A transverse slice of a normal upper abdomen at the level of the liver and 
stomach is shown. a: Normal SWR images. b: Images reconstructed with the OHR parameters. The 
increase in noise level makes the images uninterpretable
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Image analysis
all Swr- and oHr-reconstructed fdg-pet images were read independently by two 
experienced nuclear medicine physicians blinded to the final histopathological diagnosis. 
Differences between readers were settled by consensus. The visualisation, location and 
additional properties of the primary tumour and the number and location of lesions 
suspected to represent lymph node metastases were evaluated.
 
Histopathological verification
after fdg-pet, all patients but one underwent resection of the primary tumour and 
supra-omohyoidal lymph node dissection of the neck within 30 days (average 14 days), 
providing pathological findings as a gold standard. Patient 26 underwent neck dissection 
49 days after FDG-PET. The neck dissection specimens were subjected to standard 
histopathological examination. All lymph nodes were examined by standard sectioning 
and haematoxylin and eosin staining.Using the outcome of histopathological staging, the 
sensitivity, specificity and predictive values for the detection of lymph node metastases by 
FDG-PETwere calculated for both the SWR and the OHR algorithm.
 
results
 
a summary of the imaging results as compared with histological diagnosis is shown in 
table 2. Subjectively, the OHR images were easier to read. The moderately higher noise 
level was outweighed by improved spatial resolution and recognition of details in both 
normal tissue and pathological lesions. Overall, the reviewers judged the OHR images 
to be of better quality and expressed a higher confidence in the reading.
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Primary tumour lymph node metastases
sWr ohr sWr ohr nodal stage nodes (diameter)
1 + + 0 0 pn0 0
2 + + 0 0 pn0 0
3 + + 0 0 pn0 0
4 + + 0 0 pn0 0
5 + + 0 0 pn0 0
6 + + 0 0 pn1 1 (2mm)
7 + + 0 3 pn0 0
8 + + 0 1 pn0 0
9 + + 0 0 pn0 0
10 + + 0 0 pn0 0
11 + + 0 0 pn0 0
12 - + 0 0 pn1 1 (5 mm)
13 + + 0 0 pn0 0
14 + + 0 1 pn1 1 (2 mm)
15 + + 0 0 pn1 1 (2 mm)
16 + + 1 1 pn0 0
17 + + 0 1 pn1 1 (7 mm)
18 + + 0 0 pn0 0
19 + + 0 1 pn0 0
20 - + 0 0 pn0 0
21 + + 1 2 pn0 0
22 + + 0 0 pn0 0
23 + + 0 0 pn0 0
24 - - 0 0 pn0 0
25 + + 1 3 pn2b 7 (1-8 mm)
26 + + 0 1 pn2b 5 (3-5 mm)
27 + + 0 0 pn1 1 (4 mm)
28 + + 0 0 pn1 1 (5 mm)
 
Table 2: the number of primary tumours and pathological lymph nodes visualised with fdg pet on Swr 
images and OHR images. The final nodal stage was provided by histopathological examination
Primary tumours
in one patient, who had undergone an excision biopsy of the primary tumour, fdg-pet 
showed no focal pathology. SWR-based images visualised 25 primary tumours in the 
remaining 27 patients, demonstrating a sensitivity of 92%. Both missed tumours were 
staged T1 on histopathological examination. On the OHR scans, 27 primary tumours 
were visualised, demonstrating a sensitivity of 100%. Figure 3a shows an example of 
improved visualisation of a primary tumour in the head and neck with OHR images. 
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Figure 3: example slices illustrating the improvement in image quality between reconstructions with Swr 
and OHR parameters in the head and neck area. a Patient with a T1 carcinoma of the left ventral tongue. On 
the SWR images the tumour was not distinguishable from physiological tongue muscle activity. By contrast, 
it was visible on the OHR images (arrow). b patient with suspicion of one vague lymph node metastasis 
(arrow) on the SWR images. On the OHR images, multiple nodes were clearly visible (arrows). Note that 
physiological structures such as the tonsils are also more clearly visualised
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Primary tumour suvmax Primary tumour suvmean
sWr ohr increase sWr ohr increase
1 7.6 10.0 32% 5.9 7.9 34%
2 3.9 6.2 59% 2.8 3.8 36%
3 2.8 4.4 57% 2.5 3.6 44%
4 11.0 21.3 94% 6.3 11.1 76%
5 1.0 1.2 20% 0.9 1.1 22%
6 1.9 2.6 37% 1.8 2.3 28%
7 2.9 4.5 55% 2.5 3.4 36%
8 3.2 3.1 -3% 3.1 2.8 -10%
9 2.7 4.1 52% 2.5 3.5 40%
10 6.4 10.0 56% 4.0 7.1 78%
11 11.7 16.1 38% 8.2 10.3 26%
12 no suv measurable
13 3.2 4.9 53% 2.6 3.8 46%
14 6.1 7.7 26% 4.2 5.0 19%
15 3.0 3.8 27% 2.3 2.9 26%
16 4.4 6.1 39% 3.2 4.2 31%
17 1.7 2.7 59% 1.6 2.4 50%
18 4.9 7.7 57% 3.4 4.6 35%
19 2.8 4.8 71% 2.3 3.1 35%
20 no suv measurable
21 2.6 4.1 58% 2.1 3.1 48%
22 3.6 4.2 17% 3.0 3.5 17%
23 9.9 12.1 22% 7.8 9.7 24%
24 no suv measurable
25 8.3 9.5 14% 4.9 6.4 31%
26 10.9 11.7 7% 7.0 8.6 23%
27 5.8 9.0 55% 4.1 5.4 32%
28 8.5 12.4 46% 6.4 7.6 19%
avg 5.2 7.4 42% 3.8 5.1 34%
 
Table 3: Suvs measured in visualised primary tumours, in Swr images and in oHr images 
as shown in table 3, on the Swr images the mean of the Suvmean of all detected primary 
tumours was 3.8 (range 0.9–8.2) and the mean of the SUVmax was 5.2 (range 1.0–11.7). On 
the oHr images, the mean of the Suvmean was 5.1 (range 1.1–11.1) and the mean of the 
Suvmax was 7.4 (range 1.2–21.3). Using OHR, the SUVmean increased by 34% (P<0.0001) 
and the Suvmax increased by 42% (P<0.0001). As shown in figure 4, there was a strong 
linear correlation between the Suvmean values derived from Swr and oHr images 
(r=0.96), and between the SUVmax values derived from SWR and OHR images (r=0.94).
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Figure 4: the relation between measured Suvs of detected primary tumours in the head and neck area, on 
SWR and OHR images. There is a strong correlation between the values on SWR and OHR images, though 
the OHR values are markedly higher than the SWR values. left: Suvmax; right: Suvmean
Lymph nodes
the Swr-based images visualised three lymph nodes in three patients, of which only 
one was confirmed as a lymph node metastasis on pathological examination. The OHR 
based images showed 14 lymph nodes in nine patients (in other words, 11 additional 
nodes in eight patients). Four of these patients were confirmed to have metastatic lymph 
nodes in the specified region. Figure 3b illustrates the improved visualisation of lymph 
node metastases in the head and neck on OHR images. 
When calculated on a patient basis (e.g. accuracy for presence of lymph node metastases 
or not), sensitivity increased from 11% to 44% when using OHR images, while specificity 
decreased from 89% to 74%. The positive predictive value of the diagnostic procedure 
increased from 33% to 44% and the negative predictive value increased from 68% to 
74%. The diagnostic performance of SWR and OHR images for the detection of lymph 
node metastases is summarised in table 4.
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Patient basis involved neck side
sWr ohr sWr ohr
sensitivity (%) 11 44 9 45
Specificity (%) 89 74 96 87
Positive predictive value (%) 33 44 33 45
negative predictive value (%) 68 74 81 87
Table 4: diagnostic performance of fdg-pet in the detection of lymph node metastases on Swr images 
and OHR images. The values were calculated separately for detection of lymph nodes on a patient basis 
(e.g. presence of lymph node metastases or not) and on an involved neck side basis (e.g. having lymph node 
metastases on either the left or the right side)
 
With both reconstruction methods, specificity was relatively high, mainly because of a 
large number of true negatives. All missed lymph node metastases were very small, with 
a maximum diameter of 5 mm or less.
When calculated on the basis of the involved neck side (e.g. presence of lymph node 
metastases on either the left or the right side), sensitivity increased from 9% to 45% 
when using OHR images, while specificity decreased from 96% to 87%. The positive 
predictive value of the diagnostic procedure increased from 33% to 45% and the negative 
predictive value increased from 81% to 87%.
overall, when considering primary tumours and lymph node metastases on a patient 
basis, the fdg-pet diagnosis was improved by using the oHr protocol in six patients 
(21%). The FDG-PET diagnosis worsened in three patients (11%), in all cases owing to 
visualisation of lymph nodes without metastasis.
 
Discussion
 
this study shows that a general reconstruction algorithm for whole-body studies may 
be less suitable for staging malignancies in the head and neck region. Using the SWR 
protocol, the sensitivity for the presence of lymph node metastases was only 11%, which 
is considerably lower than the findings reported by some other groups2-5. The presented 
results are therefore probably specific for our situation, reflecting, for example, the type 
of PET scanner and the standard reconstruction parameters used. Factors such as the 
aforementioned may also partially explain the variable results found in literature.
using the oHr protocol we observed an increase in sensitivity for the detection of primary 
tumours, as well as an increase in sensitivity and specificity for the detection of lymph node 
metastases. From a clinical point of view, the most important improvements when using 
oHr were the increases in positive predictive value and negative predictive value for the 
presence of lymph node metastases. Where FDG-PET is used for staging, this will limit the 
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number of missed N+ stages. The benefit is even more clearly expressed by the enhanced 
performance for the detection of the involved neck side, as this has a direct impact on 
patient management. Although not investigated in the current studies, similar effects 
may apply for relapse detection, re-staging and therapy monitoring. Perhaps equally as 
important as the better objective parameters is the possible subjective gain in reviewer 
confidence in image reading.
These beneficial effects may partially be explained by the higher spatial resolution of 
OHR-reconstructed FDG-PET images. Current clinical PET scanners have a spatial 
resolution of 4–7 mm full-width at half-maximum. The detection limit for small lesions is 
in the range of 4–10 mm, depending on scanner characteristics, localisation of the lesion 
and degree of fdg uptake by the lesion11-13. Although we have not evaluated objective 
changes in scanner spatial resolution, all lymph node metastases that were additionally 
detected with OHR had a diameter of 7 mm or smaller. Another important explanation 
for the benefits is the higher contrast resolution, as a better tumour to background ratio 
facilitates visual detection of lesions. This effect was quantitatively demonstrated by a 
statistically significant increase in SUV.
although the oHr protocol delivers higher sensitivity for the detection of lymph node 
metastases, it results in a lower specificity due to visualisation of a larger number of 
small reactive lymph nodes. FDG accumulates in inflammatory cells such as activated 
granulocytes and macrophages14, and this inherent characteristic of FDG will be difficult 
if not impossible to circumvent. Although false positive in oncological staging, from a 
pathophysiological point of view these lymph nodes are true positive. One can argue that 
intentional use of suboptimal image quality is not the preferred method to discriminate 
between reactive lymph nodes and metastases. 
Several algorithms can be used for image reconstruction, such as filtered back-projection 
(FBP) or iterative ordered subset expectation maximisation (OSEM). The choice of 
image reconstruction algorithm and parameters influences the contrast resolution, spatial 
resolution and noise level. Nowadays, most investigators acknowledge that iterative 
reconstruction such as iterative oSem yields the best image quality15-18, although some 
discussion continues19. We limited this study to optimisation of iterative reconstruction, 
since FBP reconstruction has been abandoned.
in iterative reconstruction, three parameters are relevant: the number of iterations, the 
number of iteration subsets and the strength of the filter20. Essentially, increasing the number 
of iterations (and/or iteration subsets) improves spatial resolution and contrast resolution at 
the expense of higher noise levels and increased calculation time. Increasing the filter strength 
reduces noise at the expense of spatial resolution and contrast resolution. Reconstruction 
parameters are not generally applicable to all pet systems, as the results depend on camera 
characteristics, scanning mode, injected dose, the purpose of the scan and the personal 
preferences of the reviewer. Thus, optimisation of the diagnostic yield of FDG-PET by 
assessing on-site improvement of reconstruction parameters should be pursued.
64
noise in pet images is mainly caused by photon attenuation and scatter, which 
strongly depend on the amount of attenuation (i.e. the patient’s weight). The standard 
reconstruction parameters are chosen to render an optimal balance between noise levels, 
spatial resolution and contrast resolution, for an average patient. In the current study, 
more noise was observed in the OHR images by the reviewers. The somewhat higher 
increase in Suvmax as compared to Suvmean also reflected increased statistical noise. 
this did not hinder adequate reporting, as was demonstrated by the improved diagnostic 
values. An increase in lesion SUV seems to improve the sensitivity for small lesions, 
especially in the range of the detection limit. This applies not only to FDG scanning: 
lesions with a poor Suv are likely to be present when using radiopharmaceuticals with 
a relatively low target-to-background ratio, such as 18F-3’-fluoro-3’-deoxy-thymidine 
(FLT)21 or 18F-misonidazole. In these cases the improved algorithm may also be of value. 
The head and neck region is not the only area where improvement may be achieved. 
adaptation of reconstruction parameters may also improve image quality in other 
situations with relatively low attenuation, e.g. in thin body parts (such as arms, legs 
and feet) or in patients with low body weight (cachectic patients, young children). An 
important difference, however, is the variable attenuation within these patients, as 
compared with the relatively uniform and stable size of the adult head and neck. This 
implies that a standard reconstruction protocol would be less desirable, but different 
parameters need to be investigated to optimise image quality. 
 
conclusions
 
routine whole-body pet reconstruction parameters may prove inadequate for the 
head and neck area. By using image reconstruction parameters adapted to lower photon 
attenuation, major improvements may be achieved in image quality and diagnostic yield 
for the detection of small lesions. These improvements were shown to have an impact 
on staging and patient management. Additional separate reconstruction of the head and 
neck area with optimised parameters for specific clinical questions is advisable. This 
may also apply to image reconstruction of other small body parts or to whole-body 
studies in children.
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abstract
objective
pilot study evaluating the diagnostic value of magnetic resonance lymphography 
(MRL) compared with conventional imaging techniques in the preoperative staging 
of the clinically (palpable) negative neck (cN0) in squamous cell carcinoma of the oral 
cavity (SCCOC).
methods
patients with SCCoC without clinical evidence of lymph node metastasis and 
scheduled for surgery underwent mrl in combination with ultrasound with or 
without fine needle aspiration cytology and multi-detector computer tomography. 
MRL images were interpreted by 2 independent radiologists. All patients were 
planned for resection of the primary tumor and a selective neck dissection of levels 
I–III. Histopathologic results were evaluated as the gold standard and compared with 
preoperative findings.
results
One of nine evaluated patients had a metastatic node on histopathologic analysis. In 
all but 1 patient, MRL showed possible metastatic spread in at least 1 node. On a 
node-to-node basis, negative predictive value (NPV) and sensitivity reached 100% for 
1.5- en 3-Tesla (T) MRL, specificity reached 92% at 1.5 T and 93% at 3-T MRL, and 
positive predictive value (PPV) was 8% at 1.5-T MRL, for both radiologists. PPV at 
3-T MRL was 10% and 9%, for radiologists I and II, respectively.
conclusions
this prospective pilot study shows that mrl has a high npv based on a node-
to-node analysis. However, its PPV was only 10%, and therefore its use as a single 
imaging technique in the preoperative staging of the cn0 neck in SCCoC seems to 
be limited. Further studies are needed to confirm these data. 
dIAGnosTIC vAluE of MR lyMPHAnGIoGRAPHy In PREoPERATIvE sTAGInG of 
ClInICAlly nEGATIvE nECks In squAMous CEll CARCInoMA of THE oRAl CAvITy
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introduction 
Squamous cell carcinoma of the oral cavity (SCCOC) is responsible for almost 1% of 
new cancer cases in the Netherlands. The incidence of SCCOC is 4.1 per 100,000 in 
men and 2.7 per 100,000 in women1. The most important prognostic factor in SCCOC 
is probably the presence of cervical metastasis2-4. The choice of management depends 
largely on the presence and extent of metastatic disease in the neck. Identifying how 
extensive treatment should be for individual patients is of utmost importance. Therefore, 
treatment refinements, such as limitation of the field of radiation or a more selective neck 
dissection (SND) are necessary5-8.
Palpably and radiologically negative necks (i.e. staged by ultrasound [US], with or 
without [+/–] fine needle aspiration cytology [FNAC]), and/or multi-detector computer 
tomography (MDCT), and/or magnetic resonance imaging [MRI]) show occult metastatic 
spread in 20–40%, which is discovered at postoperative histopathologic examination 
after neck dissection9-19. Modern imaging techniques have so far shown inadequate 
predictability in identifying cervical metastases in the absence of palpable lymph node 
[LN] metastases)9-19. A recent meta-analysis by de Bondt et al. showed that US (+/- 
FNAC) has the best accuracy for the detection of  cervical lymph node metastases20. 
promising results in detecting small metastases by using new mri contrast agents 
(i.e. ultra-small superparamagnetic oxide nanoparticles [USPIO]) have recently been 
published21, 22. 
to date, the results in head and neck squamous cell carcinoma are sparse, but promising, 
with a reported sensitivity ranging from 86% to 96% and specificity from 77% to 100%23-25. 
However, these studies refer to heterogenic populations of patients with various head 
and neck malignancies that were mostly classified (using the Tumor Node Metastasis 
classification, TNM26) with >T2 primary tumors with clinically positive (cN+) necks, who 
were already being scheduled for therapeutic neck dissections. To our knowledge there 
are no previous studies reporting on the value of mrl in detecting occult metastatic 
disease in clinically N0 (cN0) SCCOC patients.
in the present prospective pilot study, we evaluate the added diagnostic value of mrl 
over conventional imaging methods, such as MDCT, MRI, and US (+/- FNAC) to detect 
occult metastatic disease in patients with cN0 necks in SCCOC. 
Patients and methods 
All patients diagnosed with a cN0 SCCOC between June 2005 and January 2007 and 
scheduled for Snd i–iii as part of their treatment were asked to participate in the study; 
informed consent was obtained from all patients and the study was approved by the local 
medical ethics committee. 
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Inclusion and exclusion criteria
The inclusion criteria were: (a) patients aged 18 years or older of either sex. Female patients 
were on effective contraception with a signed written informed consent; (b) patients with 
newly diagnosed, untreated SCCOC, which was histopathologically confirmed. All 
patients were scheduled to undergo excision of the primary tumor with Snd i–iii on the 
ipsilateral side within 21 days of MR imaging with the MRL contrast agent. No patient 
had clinical evidence of LN metastasis (routinely staged by means of palpation and US 
[+/- FNAC]) at the time of  initial diagnosis (cN0).
The exclusion criteria were: (a) patients with a contraindication to MR imaging; (b) patients 
with a known allergy to dextran or drugs containing iron salts; (c) with hemochromatosis; 
(d) patients who underwent chemotherapy or radiotherapy before surgery; (e) patients 
who had a previous lymphadenectomy in the head and neck region; (f) female patients 
who were breast-feeding; (g) patients participating in another clinical trial, including that 
of another contrast preparation within the last 3 months or 7 days after this study; or (h) 
patients whose degree of cooperation was incompatible with the study.
All patients were preoperatively classified using the TNM classification26. Standard 
preoperative staging of  the neck consisted of  palpation and US (+/- FNAC). Conventional 
chest X-ray was performed to exclude pulmonary metastases. Imaging results of these 
modalities only were used to define treatment.
MDCT
On day 1, an MDCT scan (Siemens, Erlangen Germany) was performed from the 
anterior skull base to the aortic arch in 2-mm reconstructions in a soft tissue algorithm 
using 100 ml Optiray 300 (Mallinckrodt Medical, Dublin, Ireland; 2 ml/sec, delay 40 
seconds). Nodes were described with reference to cervical LN level27 and in relation to 
anatomical landmarks.
USPIO
After MDCT scanning, the USPIO (Ferumoxtran-10, SINEREM©, Guerbet, France) was 
administered to the patient. USPIO was provided as a lyophilized powder consisting of 
USPIO particles covered with low-molecular-weight dextran. The contrast agent (2.6 mg 
of iron/kg of body weight) was diluted in 100 ml of saline and intravenously administered 
in a single dose by drip infusion through a filter with a 4 ml/hour drip rate. USPIO was 
administered over 30 minutes in the presence of a physician.
MRI scanning
On day 2, 24–36 hours after USPIO administration, MRL was performed. Examinations 
were carried out at a field strength of 1.5 and 3.0 Tesla (T) in all patients using a head and 
neck surface coil (Avanto and Trio, Siemens, Erlangen, Germany, respectively). For MRL 
T2* -weighted gradient echo (GRE) multiple-echo data image combination MEDIC 
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images were performed 24 hours after the administration of USPIO. As a precontrast 
MRL image, 2-dimensional (not influenced by T2* shortening and susceptibility artifacts) 
turbo spin echo (TSE) T1-true proton density (PD)-weighted images were used. The T1- 
and t2*- weighted mr images were each acquired in 2 planes, using identical position 
and resolution parameters, to enable comparison. Image planes were a semi-sagittal 
“sternocleidal” plane and an axial plane. For the USPIO-sensitive MRL images, a T2* 
(iron-sensitive) MEDIC was used. Additionally, a 3D (isometric voxel) T1- weighted GRE 
sequence (volumetric interpolated breath-hold examination) was applied. The scanned 
area extended from the clivus to the aortic arch. All sequences were performed after 
administration of the MRL contrast agent. See table 1 for scanning parameters.
sequence Direction B0 field (T) Tr (ms) Te (ms) slice (mm)
T1-PD-pre sag 1.5 411 9 3
T1-PD-pre ax 1.5 453 14 4.4
T1-PD-pre sag 3 704 13 2.5
T1-PD-pre ax 3 1040 13 4.5
meDic T2* sag 1.5 418 18 3
meDic T2* ax 1.5 567 18 4.4
meDic T2* sag 3 643 9.1 2.5
meDic T2* ax 3 1210 9.1 4.5
viBe T1 gre 3d iso-ax 1.5 8.75 4.24 0.8 iso
viBe T1 gre 3d iso-ax 3 5.09 2.45 0.65 iso
fl-3D-MRA 3d iso cor 3 3.38 1.17 1.0 iso
 
Table 1: Scanning parameters of  used sequences. 
US and FNAC
US was performed immediately after MRL by using a linear 7.5-MHz probe (ATL 
HDI 5000, ATL Philips Healthcare, Eindhoven, the Netherlands). This procedure was 
performed as the final examination to prevent artifacts caused by the cytologic aspiration 
trauma and blood products. Cervical levels I–VI27 were examined on both sides (with 
radiologists blinded to the MRL and MDCT results). All nodes were described by level 
and orientation in 2 directions (the long and short axes) in relation to the anatomical 
landmarks. If the short axis of a LN exceeded 5 mm in levels I, III–VI and 7 mm in level 
II, FNAC was performed. FNAC was limited to 1 LN on either side with a maximum of 
2 nodes. If more LNs were enlarged, the node with the largest axial diameter was chosen 
for FNAC.
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Image evaluation
All MRL, MDCT, and US examinations were evaluated by 2 radiologists (WD and RdB), 
experienced in head and neck radiology. They were blinded to each other’s results and clinical 
information, such as stage, type, and localization of the primary tumor. All images were 
evaluated and scored on a node-to-node basis as described by Lahaye et al.28 all lns were 
described by level, orientation, and anatomical landmarks. The following criteria were used 
for suspicion of LN metastasis. For MDCT and MRI, nodes with a minimal axial diameter 
exceeding 10 mm for levels i, iii–vi and 11 mm for level ii, respectively, or detection of 
central necrosis, were considered to be malignant13, 16, 19, 29. For MRL, TSE-PD-T1-weighted 
(iron insensitive) and T2*-GRE (iron sensitive) images were compared. LNs were scored at 
3 levels (A, B or C) in order to assess the level of suspicion (see figure 1 [Lahaye et al.28 and 
de Bondt et al.30]). LNs with a homogeneous signal intensity (SI) decrease on GRE images 
compared with SI on TSE images, with or without only small inhomogeneities (less than 
30% of the node on its largest image) were considered normal28, 31. LNs with an area of 
30% or more with no signal drop (i.e. category B and C) on GRE images were considered 
metastatic: nodes with an area of 30–50% of signal drop were scored ‘B’ and nodes with an 
area of >50% of signal drop were scored ‘C’. A T1 flash 3D magnetic resonance angiography 
(MRA) sequence was used to display the anatomical location of the nodes in relation to the 
vessels to the surgeon preoperatively.
Figure 1: Different categories of  nodal MRL staging (modified scheme from de Bondt et al.30 and lahaye 
et al.28)
Surgical protocol
SND (as described by Medina and Byers32) of levels I–III was performed on the side 
affected by the primary tumor. If suspicious nodes were found at MRL outside the standard 
surgical field of view (i.e. homolateral levels I–III), but close to the midline, the SND 
was extended to incorporate the suspicious node. after the resection, the neck dissection 
specimen was pinned to a standardized grid of the neck and a digital photograph was 
taken of  the specimen on the grid for correlation. 
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Histology
The pathologist manually identified and localized the LNs per neck level and anatomical 
landmark in the specimen in combination with the digital photograph in order to optimize 
node-to-node correlation. The maximum short axial diameter of all LNs in the dissection 
specimen was recorded, followed by fixation of LNs, sectioning, and hematoxylin–eosin 
(HE) staining. Hereafter, each LN was examined microscopically (4-µm specimens, every 
2–3 mm) and the image digitalized. Special attention was paid to nodal characteristics: 
the presence of histiocytosis, follicular hyperplasia, and the amount of iron were scored, 
the latter by Perls’ staining method. this histopathologic analysis was used as the gold 
standard to determine the LN status. The classification of the American Joint Committee 
on Cancer26 was used for pN staging of the neck.
Combined data analysis
The results of  the measurements on MRI, MDCT, and US (+/- FNAC) were subsequently 
compared with the results of mrl and the pathologic examination of the neck dissection 
specimens. Correlation was based on node-to-node analysis of neck levels. Combining 
the maximum short axial diameter and the exact location of each ln per neck level 
(in relation to the surrounding anatomic structures, such as blood vessels, muscles, and 
salivary glands) a topographic correlation for each LN between the histopathologic 
examination and the MRL, MDCT, US, and MRL images was made possible. Statistical 
analysis was performed using SPSS 16.0©.
results
Sixty-nine eligible patients were encountered. However, due to concurrent studies and a lack 
of interest and enthusiasm only eleven patients underwent mrl and conventional imaging; 
2/11 were not surgically treated due to rapid growth of their primary tumor. Thus 9/11 
patients were included (4 males, 5 females). Four tumors were clinically staged T2N0M0, 5 
were staged T1N0M0. No tumor crossed the midline. Five tumors were located on the lateral 
side of the oral tongue, 2 in the floor of the mouth, 1 on the alveolar process and 1 in the 
buccal gingiva. One LN was found to contain metastatic cells during histopathologic analysis.
Based on US, the radiologist found no reason to perform FNAC in 4/9 cases (44%). In the 
remaining 5, FNAC was performed revealing no metastatic cells. MDCT scanning showed 
4 patients with possible metastatic nodes; in 3/4 cases fnaC was later performed during 
US investigation (and was negative); in 1 case, US did not indicate the positive node on CT 
as suspect and no FNAC was performed. US (+/- FNAC) correctly staged 8 necks as true-
negative, 1 was false-negative; mdCt correctly staged 5 necks as true-negative, 3 were false-
positive and 1 was true-positive. For an overview of preoperative imaging results, see table 2. 
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Patient 
no.
T-stage us Fnac cT
mrl 
1.5T
mrl 
3 T
histopathological 
examination
i 1  - np - + + -
ii 2 * neg + + + -
iii 2 - np - + + -
iv 1 - np - + + -
v 2 * neg - + + -
vi 1 - np + + + -
vii 1 * neg + + + -
viii 1 - np - - - -
iX 2 * neg + + + +
Table 2: Nine patients with their positive (+) or negative (-) preoperative staging modalities. Neg = no tumor 
cells. NP = Not Performed. US is scored ‘*’ when size was reason to perform FNAC
No adverse events were recorded during the administration and use of USPIO. 
With MRL, 1 patient was true-positive, 1 true-negative, and 7/9 were false-positive. On 
a node-to-node level, a total of 143 nodes were histopathologically correlated, of which 
13/143 and 12/143 were scored positive by radiologist I and II, respectively, at 1.5-T 
MRL, and 10/143 and 11/143, respectively, at 3-T MRL. There were 3 patients with 1 
node scored in the ‘B’ category: 1 at 3-T MR-imaging and 2 at 1.5-T MR-imaging: all 3 
were scored negative on histopathalogical examination. The majority of suspicious nodes 
on MRL (either 1.5 or 3 T) had a minimal axial diameter of 4–6 mm.
there was only 1 histopathologically proven positive ln: this node was positively 
correlated and showed a minimal axial diameter of 8 mm at 1.5 T and 9 mm at 3 T and 
was scored as ‘A’ in both modalities. At postoperative histopathologic examination, the 
node was 12 mm in minimal axial diameter and showed extracapsular spread. Examples 
of mrl images are shown in figures 2 and 3. 
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    2a  2B 2C
Figure 2: figure a shows a sagittal tSe-pd-weighted image of  a normal level iiB 3 mm node with a high 
signal intensity (SI) center in the fatty hilum. In figure B, the high SI vanishes due to the fat saturation of the 
T2*-weighted sequence. Due to USPIO (iron) accumulation in the LN the entire node has a low SI on the T2*-
weighted image corresponding with a non-metastatic node. Figure C is the corresponding hematoxylin–eosin 
macroscopic histology showing a normal lymph node. Due to the partial volume, the fat cells are not represented 
in the histological specimen.
 
 
3a  3B  3C 3d
Figure 3: Example of a false-positive lymph node on magnetic resonance lymphography.This figure demonstrates 
a lymph node in a patient (female 64 years, T1 tongue margin carcinoma) on level IIA, right. In figure A and B, this 
node (5 mm short axis) is shown in axial and sagittal view on (A) T2* and (B) T1-PDW TSE. This node has a bright 
hilum in the cortical area on T1 without signal drop on T2*. Figure D demonstrates the macroscopic resemblance of 
the lymph node. Histology showed a lymph node with small foci of chronic inflammation with foamy macrophages. 
These areas do not accumulate USPIO. 
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On a node-to-node analysis, no significant correlation could be found between any of  
the examined nodal characteristics (presence of  histiocytosis, follicular hyperplasia, or 
the amount of  iron) and false-positive results. All but 1 patient had at least 1 USPIO-
positive suspicious node, both on 1.5- and 3-T MRL, with a maximum of  4 suspicious 
nodes in 1 patient. No false-negatives were found in this small group of  patients leading 
to a negative predictive value (NPV) of  100% in both radiologists’ results (for both 1.5- 
and 3-T imaging, node-to-node analysis). Node-to-node positive predictive value (PPV) 
reached 8% for both radiologists in 1.5-T interpretations. In 3-T imaging, PPV reached 
10% and 9% for radiologist I and II, respectively. By node-to-node analysis a sensitivity of  
100% (for both radiologists’ results) is reached. Specificity was equal for both radiologists 
as well and reached 92% in 1.5-T imaging and 93% in 3-T imaging. For a comparison of  
both radiologists’ results and the number of  detected nodes, see table 3. 
size node 
(mm smallest 
axial dm)
a 
(1,5Tesla)
B 
(1,5Tesla)
c 
(1,5Tesla)
a 
(3Tesla)
B
(3Tesla)
c 
(3Tesla)
2 -/- -/- -/- -/2 -/- -/-
3 2/3 1/1 -/- 1/1 -/- -/-
4 13/10 -/1 -/- 7/7 -/1 -/-
5 8/9 2/2 -/- 10/6 2/2 -/-
6 11/7 3/2 -/- 6/6 3/3 -/-
7 4/2 2/1 -/- 4/3 -/- -/-
8 -/- 1/2 -/- -/- 1/1 -/-
9 -/- 2/1 1/1 -/- 2/3 1/-
11 -/- -/- 1/1 -/- 1/1 -/-
12 -/- -/- -/- 1/1 -/- -/-
Total 38/31 11/10 2/2 29/26 9/11 1/0
Table 3: results of  mrl: number of  nodes scored positive by reader i and reader ii
a-C: categories of possible metastatic involvement in lymph nodes, see figure 1
Discussion
we performed a pilot study on the use of mrl in cn0 SCCoC to investigate whether 
this preoperative imaging modality could have additional value to our standard workup 
consisting of  palpation and US (+/- FNAC). 
many staging techniques have been under investigation and have been described for the 
preoperative staging of the cn0 neck in SCCoC in order to lower the amount of false-
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negative necks to 20% or less33: this could lead to a change in treatment for this group of 
patients by avoiding Snd in patients with a cn0 neck, thereby reducing postoperative 
morbidity. 
mrl has been shown to be a reliable tool to differentiate benign from malignant lns in 
animals34, 35 and in several human malignancies21, 22, 36-38. 
In the field of head and neck oncology, some studies have been performed with promising 
results: Mack et al.23 analyzed a heterogenic group of 30 patients with a sensitivity of 86% 
and specificity of  100%. 
A phase III, multicenter, clinical trial by Sigal et al.24 showed a sensitivity of 88% and a 
specificity of 77% for MRL for imaging of individual LNs in 81 patients with different 
types of head and neck SCC with relatively high T-stages (11 T1, 29 T2, 28 T3, 10 T4, 
and 5 Tx tumors), of which 28 were cN0 (palpation only). Twelve patients had occult 
metastatic spread (42%). MRL in cN0 patients was less reliable when compared with 
the whole group. A study by Curvo-Semedo et al.25 of 20 patients with different head 
and neck carcinomas (no SCCOC) showed a sensitivity of 96% and a specificity of 79%; 
accuracy was 86%. However, in their cohort, only 1 T1 tumor was included and 13 of 20 
patients were staged cN+. 
In our small though homogenic cohort, US (+/- FNAC) correctly identified 8/9 true-
negative necks and MDCT correctly identified 4/9 true-negative necks. Considering our 
MRL results, the majority of ‘suspect’ LNs had a size well below the current malignancy 
criteria of  MDCT, MRI, and US (+/- FNAC) for LNs of  the neck with metastatic spread; 
in addition, the (considered) metastatic part of the lymph node in the majority of nodes 
was even smaller (30–50% of the already small node). 
The 1 histopathologically confirmed metastatic node was positively identified by MRL: 
this fact seems of  little importance considering the high amount of  false-positive results. 
there could be a number of reasons for the high amount of false-positives: the amount 
of lns in the head and neck region is higher than in the pelvic area, and probably more 
susceptible to inflammatory changes due to, for instance, frequently occurring upper 
airway infections. Chronically active LNs (due to, for instance, chronic rhinosinusitis or 
chronic tonsillitis) could cause changes in the uptake of USPIO. It is thought that this 
is caused by a reduced uptake of uSpio due to hyperplasia of the germinal centers, 
and lack of macrophages in that center; macrophages only appear in the periphery 
of the node24, 25. A different USPIO uptake by macrophages in the LNs of the neck 
might also explain some of the differences: for instance hyaline metamorphosis (e.g. 
conversion of cells and intercellular substance into hyaline material, possibly due to 
recurrent infections or malnutrition) might cause false-positive results, as could focal 
fibrosis or focal granulomatosis28; however, we could not confirm this finding during 
our histopathologic research. Benign space-occupying lesions, such as sinus histiocytosis 
or extensive follicular hyperplasia, seemed to play no role in false-positive results in our 
study. In a study by Rety et al.39, differences in distribution by USPIO were described. In 
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their study, subdiaphragmatic LNs exhibited a higher uptake than supradiaphragm LNs. 
Furthermore, Wagner et al.40 described that after an intravenous injection, nanoparticle 
uptake in central LNs (mesenteric and mediastinal) is always higher than in peripheral 
LNs. An important explanation may also be the possible lack of sensitivity of the current 
‘gold standard’ of histopathologic examination: perhaps more small metastatic nodes 
would be identified by adding immunohistochemistry and multi-slice sectioning of all 
LNs. 
the limitations of our study are the small sample size and the fact that only 1 node 
was a metastasis. Furthermore, only T1 and T2 tumors were included, which could bias 
the results for the whole cN0 group of patients. In patient groups with a higher pretest 
probability of metastatic disease (cN+ necks) USPIO-enhanced MRL has been proven 
to perform better23-25. The fact that no immunohistochemistry and multi-slice sectioning 
were performed and unfortunately, the lack of histopathologic explanation for the high 
number of false-positive findings also are limitations to the study. Finally, the used 
interpretation scheme for measurement of metastatic spread in lns, which is different 
from that described by, for instance, Harisinghani et al.41 and Heesakkers et al.31 may 
have influenced the results. However, no study has focused on this specific cN0 SCCOC 
group of patients and performed a node-to-node analysis before. 
a negative preoperative mrl might prove to be an indicator of a truly histopathologically 
proven negative neck and could perhaps, if future research would confirm our findings, 
lead to less SNDs being performed. The combination of MRL (with a high sensitivity) 
with US (+/- FNAC) (with a high specificity) might prove to be useful in preoperative 
assessment. However, a lot of preoperative scans would have to be performed to identify 
1 truly negative neck. Research in a larger cohort is mandatory. 
Production of the USPIO contrast agent by Guerbet (SINEREM©, France) was recently 
discontinued. However, new USPIO agents with comparable characteristics will become 
available in the near future.
conclusions
this pilot study shows that mrl, in its current form, in low-stage SCCoC has a high 
amount of false-positive results when compared with standard imaging and histopathologic 
analysis. However, its NPV and sensitivity in this small group of patients seem high 
and a combination with US (+/- FNAC) might prove to be promising. More research 
confirming these results and concerning the rationale behind the high amount of false-
positive findings is needed. 
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abstract
objective
In squamous cell carcinoma of the oral cavity (SCCOC) regular follow-up comprises 5 
years of prescheduled visits regardless of tumor stage and/or treatment. We analyzed 
our standard treatment- and follow-up protocol in patients with a preoperative 
clinically negative neck (cN0) in SCOCC.
methods
this is a retrospective chart analysis. Inventarisation of treatment, occult metastatic 
spread and follow-up was performed. 
results
One-hundred-and-ninety-seven patients were included. The occult metastatic rate 
was 24%. Eighty-three percent of recurrent disease presented within 2 years. Fifty-
three percent of the patients with recurrent disease visited their physician outside 
prescheduled control visits.
conclusions
Ultrasound-guided fine needle aspiration cytology currently is one of the most reliable 
staging techniques in cN0 SCCOC. Regular follow-up could perhaps be limited from 
5 to 2 years of prescheduled follow-up visits.
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introduction 
one of the most controversial items in head and neck remains the treatment of the 
clinically negative neck (cN0) in squamous cell carcinoma of the oral cavity (SCCOC) due 
to the presence of occult metastases. Control of the primary tumor can usually be achieved 
by surgery and in some cases by radiotherapy. Tumor treatment failure is often due to 
metastatic spread to cervical lymph nodes, reducing survival by approximately 50%1-3. 
Management of the cN0 neck is therefore considered crucial. Three options are available: 
elective neck dissection, primary radiotherapeutic treatment or a ‘wait-and-see’ policy. 
the rationale behind the latter is that 60-80% of patients who undergo elective neck 
dissection are in fact being overtreated, leading to increased morbidity. A ‘wait-and-see’ 
policy requires careful monitoring of the neck over time, in combination with ultrasound 
(US) and/or ultrasound-guided  fine needle aspiration cytology (FNAC). Should a positive 
lymph node be detected during follow-up, different types of salvage neck dissection can 
be performed. With this strategy, some studies have found recurrence rates comparable 
to those for elective treatment of the neck4,5. 
However, other studies (which did not include US (+/- FNAC) during follow-up for the 
neck) reported lower survival rates in patients following a wait-and-see policy6,7 when 
compared to patients treated by elective neck dissection. 
Given these considerations, we have firstly evaluated the results of our standard 
surgical treatment with elective neck dissection for patients suffering from SCCOC. We 
furthermore especially focused on the recurrence rate of regional disease following elective 
neck dissection with special emphasis on the follow-up schedule which is advocated in the 
national guideline for oral carcinoma issued by the Dutch Cancer Society.
materials and methods 
in this retrospective study, the medical records of all consecutive patients with histologically 
proven SCC of the oC who presented at the radboud university nijmegen medical 
Center between 1st January 1992 and 1st December 2004 were reviewed. Patients with 
a cn0 neck staged through palpation and uS who underwent selective neck dissection 
of  levels I-III (supraomohyoidal neck dissection [SOHND]) as described by Medina et 
al.8, as a staging procedure and as part of their treatment, were included. In all cases a 
preoperative US (+/- FNAC) examination of  the neck was performed. If  a suspicious 
lymph node (or nodes) with a minimum diameter > 5 mm was found by US, fine needle 
aspiration cytology was performed. A conventional chest X-ray was performed in every 
patient. CT and/or MRI scanning were performed only in case of doubts concerning 
primary tumor extension (e.g. bone involvement). Patients who had suffered from head 
and neck squamous cell carcinoma (HNSCC) five years prior to their current treatment or 
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who had received radiotherapeutic or chemotherapeutic treatment for any kind of disease 
during this period were excluded. 
Surgery was performed by five experienced head and neck surgeons. In the majority 
of cases a frozen stage section (FSS) of the neck specimen was performed during the 
operation: suspicious nodes and/or the largest jugulodigastric and most distal jugulo-
omohyoid node were sampled. If FSS during the operation revealed metastatic disease, 
selective neck dissection of levels I-III was routinely extended to a modified radical neck 
dissection (MRND), encompassing levels I-V. After the resection specimen had undergone 
standardized marking, it was sent to the department of pathology where it was examined 
using standardized sectioning and haematoxylin eosin (HE) staining.
The detection of two or more histopathologically confirmed metastatic lymph nodes and/
or the presence of extracapsular spread (ECS) were absolute indications for post-operative 
radiotherapeutic treatment. Tumor-positive resection margins were an indication for 
radiotherapeutic treatment of the primary site. Relative indications for postoperative 
radiotherapeutic treatment were: tumor invasion of the mandible, one metastatic lymph 
node, close resection margins (<5 mm), angiolymphatic invasion, perineural invasion and 
a diffuse pattern of  tumor growth. Local recurrence is defined as a recurrence at the 
original site within 5 years following therapeutic excision. After this time, local tumor 
growth is considered to be a secondary primary tumor. Regional recurrence is defined 
as metastatic neck disease which does not affect structures of the oral cavity. Distant 
metastasis is defined as tumor spread from the primary tumor to distant organs or distant 
lymph nodes (e.g. not the neck). 
the recommended follow-up comprises 5 years of regular prescheduled visits9. The 
minimum follow-up period in this study was 5 years. Our standard follow-up schedule 
consisted of visits every 2 months during the first year after surgical treatment, every 3 
months during the second year, every 4 months during the third year and every 6 months 
during the fourth and fifth year. Hereafter, in the absence of any signs of recurrence or 
metastatic spread, patients were discharged.
Survival curves were estimated with the Kaplan-meier approach based on overall survival 
(OS) and disease-free survival (DFS). OS was calculated from the date that patients were 
surgically treated, while dfS was calculated using the date of detection of recurrent 
disease. Log rank tests were used to compare the study groups. 
results 
One hundred and ninety-seven patients were included: 125 males (63%) and 72 females 
(37%). Their age ranged from 27 to 90 years at the time of their operation (mean age: 62 
years). The distribution of T-stages and tumor locations is shown in table 1. 
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c Tn-stage
retromolar 
trigone
Floor of  
the mouth
lateral 
tongue
alveolar 
process
Buccal 
mucosa
Total
Txn0m0 0 1 1 0 0 2
T1n0m0 8 18 33 2 1 62
T2n0m0 7 47 41 4 4 103
T3n0m0 0 6 10 1 0 17
T4n0m0 5 4 0 4 0 13
Total 20 78 85 11 5 197
Table 1: preoperative clinical TNM-classification and location of 197 primary tumors 
All patients were preoperatively staged cN0 through palpation and US. In 50 out 
of 197 cases (25%; 220 necks) US (+/- FNAC) was performed. A total of  48 neck 
specimens (24% of patients) showed regional metastatic spread during postoperative 
histopathological examination; 1 specimen was bilaterally positive (49 pN+ necks). 
In a total of 30 T3 and T4 tumors five times a Thiersch graft was used to close the site of 
the excised primary tumor. In 16 cases extensive reconstructive surgery of the primary 
site was performed: 10 free flap soft tissue transfers were performed, as were 6 bone 
reconstructions, combined with soft tissue reconstructions. In 9 of these 30 cases the 
wound could be closed primarily.
In total, 76 metastases were found in 48 patients. No metastatic nodes were found 
in additionally resected neck levels (levels IV and V), performed after positive FSS. 
Histopathological staging of  the neck yielded the following findings: 149 pN0, 33 pN1, 
14 pN2b and 1 pN2c (68 stage I, 63 stage II, 36 stage III and 30 stage IVA tumors).
twenty-two patients had absolute indications for postoperative radiotherapeutic 
treatment based on their neck staging (7 had one metastasis with ECS, 4 had two or 
more metastatic lymph nodes with eCS, and 11 cases had more than 2 tumor-positive 
nodes). Fifteen of these 22 patients actually received postoperative radiotherapeutic 
treatment (one of the remaining 7 patients died shortly after surgery due to massive 
aspiration and the condition of the other 6 patients was too poor to administer adequate 
treatment). Sixty-two patients received radiotherapeutic treatment based on primary 
tumor characteristics.
Forty patients (20% of patients) suffered from local, regional or distant recurrence. For 
an overview of their respective ct- and ptn-stages, see table 2. 
Fourteen of these patients initially presented with regional recurrence (7% of 197 
patients). Of 149 pN0 necks, 9 patients (6%) developed initial regional recurrent 
disease, while 3 of the 48 patients with pN+ necks (6%) initially presented with 
regional recurrence. In 1 of these 12 patients level IV (combined with level III) showed 
metastatic disease. Two more patients presented with regional recurrent disease, but 
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also suffered from a secondary primary tumor and the origin of regional disease was 
unclear. Six of 30 patients who had undergone extensive reconstructive surgery suffered 
from recurrence: 3 local recurrences and 3 regional recurrences.
no. of  
tumors
cTnm
pT1n0 pT2n0 pT3n0 pT4n0 pT1n1
Txn0m0 0 0 0 1 0
T1n0m0 4 3 0 1 2
T2n0m0 2 10 0 0 1
T3n0m0 0 1 0 1 0
T4n0m0 0 1 0 1 0
Total 6 15 1 3 3
Table 2: distribution of clinical and pathological tnm stages in 40 patients suffering from recurrent disease
Twenty-four patients initially presented with a local recurrence (12% of 197 patients), while 
the remaining 2 patients had distant metastatic disease only without locoregional residual 
disease. 
Fourteen of the 40 patients with recurrent disease were palliatively treated (35%). Nineteen 
patients with recurrent disease underwent salvage surgery and 9 of these patients also received 
radiotherapeutic treatment. Six patients received curative radiotherapeutic treatment. One 
patient was treated in a different hospital for recurrent disease and was lost to follow-up.
of the 19 patients treated by salvage surgery with or without additional radiotherapeutic 
treatment, 11 died of recurrent disease (58%), a further 2 died of a second primary tumor, 1 
died of an unrelated disease. Five of these 19 patients were disease-free at the end of follow-
up. All 6 patients treated with curative intent by radiotherapy died of recurrent disease. In 
total, 17 of 25 curatively-treated patients (68%) died because of recurrent disease, 5 were 
alive and free of disease at the end of follow-up, 2 died from second primary tumors and 
1 patient died due to cardiovascular disease. This means that 20 out of 25 patients (80%) 
were dead within 5 years of treatment for recurrent disease. In other words, 78% of patients 
presenting with recurrent disease died a tumor-related death.
The mean follow-up duration was 46 months (3.8 years; median 60 months, minimum of 
0 months, maximum of 60 months). the mean time between primary curative surgery and 
appearance of recurrent disease was 15 months (1.25 years; median 10 months, minimum 
2 months, maximum 58 months). Eighty percent of recurrences appeared within 20 months 
after primary curative surgery, 83% within 2 years from treatment and 90% within 3 years 
from treatment.
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In terms of presentation of recurrent disease, 16 patients (40%) presented with signs of 
recurrent disease during prescheduled routine visits. Twenty-one patients (53%) visited their 
oncologist at their own request with symptoms related to their recurrent disease, and for 
3 patients (7%) it was not possible to ascertain when the recurrent disease was detected in 
these patients.
Finally, figures 1 and 2 show the overall survival and disease-free survival, respectively, in 
cN0 SCC of the OC. Five-year overall survival was 67% (figure 1). Five-year disease-free 
survival was 93, 80, 85 and 63% in stage I-IVA respectively (figure 2). 
 
pT2n1 pT4n1 pT2n2b pT3n2b pT4n2b
0 0 0 0 0
0 0 0 0 0
4 0 5 0 0
0 0 0 1 0
0 1 0 0 1
4 1 5 1 1 40
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Figure 1: cumulative overall survival (months)
 
Figure 2: cumulative disease-free survival (months) related to post-operative tumor stage
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Discussion
Our results confirm that, to date, selective neck dissection of levels I-III (formerly SOHND) 
remains the most important diagnostic tool in clinically n0 squamous cell carcinoma of 
the oral cavity. In a widely-accepted proposed treatment strategy, Weiss et al.10 estimate 
that if there is a greater than 20% probability of finding occult metastatic spread during 
histopathological examination of cn0 necks in SCC of the oC, elective treatment of 
the neck should be performed. The preoperative use of US (+/- FNAC) combined with 
standard histopathological examination of the dissection specimen revealed a comparable 
percentage of occult metastases when compared to preoperative staging by Ct, mri or 
fdg-pet followed by histopathological staging4,5,11-15, although its use is still not widely 
accepted. This finding has been previously mentioned by authors such as van den Brekel 
et al.4,5 and Nieuwenhuis et al.,16 who even propose a ‘wait-and-see’ policy for a cN0 neck 
in certain cases of head and neck SCC. 
in the current study the percentage of occult metastatic spread and recurrent disease is 
comparable to previously-published data12,14,17.
Six percent of patients with a pn0 neck as well as 6% of patients with a pn+ neck 
developed an initial regional recurrence. If more sensitive histopathological techniques 
would have been used (like for instance the use of immunohistochemistry and improved 
serial sectioning) perhaps more pN+ necks would have been identified. Selective neck 
dissection would then have been even more therapeutic than we think since those necks, 
scored pn0, do not show more recurrent disease than pn+ necks of which most are 
additionaly treated.
We found no so-called ‘skip metastases’ in our neck dissection specimens: of course, 
aforementioned limitations of standard histopathological workup could also influence 
these numbers. Furthermore, only 1 initial regional recurrence involved level IV and 
therefore, in this group of patients, addition of level iv to standard treatment of the 
neck (as proposed by a number of authors21,22) does not seem justified. With postoperative 
radiotherapeutic treatment on indication this group of cn0 SCCoC has a 5-year disease-
free survival of 83%.
the main goal of strict follow-up schedules would be to signal recurrent disease at an 
early stage, preferably leading to more successful salvage treatment. More than half of the 
patients who had recurrent disease made an extra appointment that led to the detection. 
despite salvage treatment, however, survival rates decline dramatically with recurrent 
disease. This leads to questions regarding the follow-up schedule proposed in the Dutch 
national guideline for oral cavity carcinoma issued by the Dutch Cancer Society. For 
example, could prescheduled visits be limited? Could patients be better informed about 
the signs of possible recurrent disease and could regular visits even be abandoned? 
in terms of costs, 76% of patients in this study with cn0 oral cavity carcinoma underwent 
elective treatment of  the neck without any signs of  postoperative metastatic spread. 
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Sixty-three percent of patients (124/197) remained disease-free postoperatively during 
follow-up. In other words, 63% of patients were intensively followed during the course of 
5 years, involving high costs. Van den Brekel et al.5 showed that in a group of mainly t1 
and T2 oral tumors strict follow-up of the neck using US (+/- FNAC) every 2 to 5 visits 
(prescheduled visits every 4-8 weeks during the first year) could possibly replace elective 
neck dissection. In terms of our cohort, this would imply a total of 992 visits (8 visits per 
year on average), 310 ultrasounds (2.5 per year on average) and at least as many fine 
needle aspiration biopsies in 124 disease-free patients during the first year of follow-up 
alone. Of course, in case of more advanced c- and pTN stages, especially after extensive 
reconstructive surgery, one would prefer to see the patient on a frequent basis, due to 
a higher chance at postoperative complications, a more prolonged recovery time and 
probably a higher need of psychosocial assistence.
the use and duration of follow-up has been questioned over the past few decades23-27. 
Not only in SCC of the OC, but also in other fields of medicine, has it been shown that 
prescheduled follow-up visits probably do not improve chances at more early detection 
of recurrent disease. For instance, Ritoe et al.27 showed that for laryngeal cancer treated 
primarily by radiotherapy, only 2% of the total number of routine visits revealed 
subclinical recurrent disease. 
follow-up after curative treatment of oral carcinoma has a number of goals: early 
identification of recurrent disease or second primary tumors and early curative treatment 
if possible; psychosocial help, registration of late complications following therapy and 
evaluation of treatment. The value of follow-up depends largely on certain parameters 
such as whether a feasible treatment for recurrent disease is available, whether early 
detection improves patient survival, and whether there is a proper diagnostic test (e.g. 
good sensitivity/specificity) to rule out recurrent disease.
if we consider these parameters in the context of our study, we have shown that our 
treatment for recurrent disease only saves 22% of patients with recurrent disease. Our 
study shows that over half of patients with recurrent disease visit their treating surgeon 
outside the prescheduled visits. Finally, the diagnostic tests are the same as those used 
during preoperative staging (inspection, palpation and US [+/- FNAC]) and have the 
same limitations. Five out of 197 patients benefitted from the detection of their recurrent 
disease as they survived after salvage treatment. Three of these 5 recurrences were 
detected at prescheduled follow-up visits, 2 were detected at extra visits on the patients’ 
own request. The necessity and cost-effectiveness of a routine follow-up schedule can thus 
be questioned as there is a very limited effect on survival. However, from a psychosocial 
perspective (for instance rehabilitation after extensive surgery) routine follow-up is, of 
course, valuable, as well as in the evaluation of complications and treatment, especially 
in patients who underwent extensive reconstructive surgery. Merkx et al.9 have already 
called for a reduction in the number of years of follow-up from 10 to 5 years. We would 
suggest that in curatively treated oral carcinoma, especially in low stage tumors, the 
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number of years of routine follow-up could perhaps be reduced from 5 to 2 years as a 
next step in limiting prescheduled doctor visits. 
conclusions
Selective neck dissection of level i-iii remains a reliable staging procedure in cn0 
SCCOC and appears to have therapeutic value as well. There is no indication for a 
level IV dissection. In case of recurrent disease, survival rates drop dramatically despite 
treatment. Long-term routine follow-up in case of cN0 oral SCC is of very limited benefit 
in terms of patient survival and could perhaps be limited to 2 years, leading to more cost-
effective postoperative treatment.
CHAPTER 5
96
reference list
1.  Leemans CR, Tiwari R, Nauta JJ, van dW, I, Snow GB. Regional lymph node involvement and its 
significance in the development of distant metastases in head and neck carcinoma. Cancer. 1993;71:452-456.
2.  Leemans CR, Tiwari R, Nauta JJ, van dW, I, Snow GB. Recurrence at the primary site in head and neck 
cancer and the significance of neck lymph node metastases as a prognostic factor. Cancer. 1994;73:187-190.
3.  Snow GB, Annyas AA, van Slooten EA, Bartelink H, Hart AA. Prognostic factors of neck node metastasis. 
Clin Otolaryngol. 1982;7:185-192.
4.  van den Brekel MW, Castelijns JA, Stel HV et al. Occult metastatic neck disease: detection with US and 
US-guided fine-needle aspiration cytology. Radiology. 1991;180:457-461.
5.  van den Brekel MW, Castelijns JA, Reitsma LC, Leemans CR, van dW, I, Snow GB. Outcome of 
observing the N0 neck using ultrasonographic-guided cytology for follow-up. Arch Otolaryngol Head Neck 
Surg. 1999;125:153-156.
6.  Kligerman J, Lima RA, Soares JR et al. Supraomohyoid neck dissection in the treatment of  T1/T2 
squamous cell carcinoma of oral cavity. Am J Surg. 1994;168:391-394.
7.  Cunningham MJ, Johnson JT, Myers EN, Schramm VL, Jr., Thearle PB. Cervical lymph node metastasis 
after local excision of early squamous cell carcinoma of the oral cavity. Am J Surg. 1986;152:361-366.
8.  Medina JE, Byers RM. Supraomohyoid neck dissection: rationale, indications, and surgical technique. 
Head Neck. 1989;11:111-122.
9.  Merkx MA, van Gulick JJ, Marres HA et al. Effectiveness of routine follow-up of patients treated for T1-
2N0 oral squamous cell carcinomas of the floor of mouth and tongue. Head Neck. 2006;28:1-7.
10.  Weiss MH, Harrison LB, Isaacs RS. Use of decision analysis in planning a management strategy for the 
stage N0 neck. Arch Otolaryngol Head Neck Surg. 1994;120:699-702.
11.  Manni JJ, van den Hoogen FJ. Supraomohyoid neck dissection with frozen section biopsy as a staging 
procedure in the clinically node-negative neck in carcinoma of the oral cavity. Am J Surg. 1991;162:373-376.
12.  van den Hoogen FJ, Manni JJ. Value of the supraomohyoid neck dissection with frozen section analysis as 
a staging procedure in the clinically negative neck in squamous cell carcinoma of the oral cavity. Eur Arch 
Otorhinolaryngol. 1992;249:144-148.
13.  van den Brekel MW. Lymph node metastases: CT and MRI. Eur J Radiol. 2000;33:230-238.
14.  Stuckensen T, Kovacs AF, Adams S, Baum RP. Staging of the neck in patients with oral cavity squamous 
cell carcinomas: a prospective comparison of PET, ultrasound, CT and MRI. J Craniomaxillofac Surg. 
2000;28:319-324.
15. Wensing BM, Vogel WV, Marres HA et al. FDG-PET in the clinically negative neck in oral squamous cell 
carcinoma. Laryngoscope. 2006;116:809-813.
16.  Nieuwenhuis EJ, Castelijns JA, Pijpers R et al. Wait-and-see policy for the N0 neck in early-stage oral 
and oropharyngeal squamous cell carcinoma using ultrasonography-guided cytology: is there a role for 
identification of the sentinel node? Head Neck. 2002;24:282-289.
17.  Results of a prospective trial on elective modified radical classical versus supraomohyoid neck dissection in 
the management of oral squamous carcinoma. Brazilian Head and Neck Cancer Study Group. Am J Surg. 
1998;176:422-427.
oRAl squAMous CEll CARCInoMA And A ClInICAlly nEGATIvE nECk: 
THE vAluE of folloW-uP
97
CHAPTER
5.0
18.  Dias FL, Kligerman J, Matos dS et al. Elective neck dissection versus observation in stage I squamous cell 
carcinomas of the tongue and floor of the mouth. Otolaryngol Head Neck Surg. 2001;125:23-29.
19.  Keski-Santti H, Atula T, Tornwall J, Koivunen P, Makitie A. Elective neck treatment versus observation 
in patients with T1/T2 N0 squamous cell carcinoma of oral tongue. Oral Oncol. 2006;42:96-101.
20.  Kerrebijn JD, Freeman JL, Irish JC et al. Supraomohyoid neck dissection. Is it diagnostic or therapeutic? 
Head Neck. 1999;21:39-42.
21.  Byers RM, Weber RS, Andrews T, McGill D, Kare R, Wolf P. Frequency and therapeutic implications of 
“skip metastases” in the neck from squamous carcinoma of the oral tongue. Head Neck. 1997;19:14-19.
22.  Shah JP, Candela FC, Poddar AK. The patterns of cervical lymph node metastases from squamous 
carcinoma of the oral cavity. Cancer. 1990;66:109-113.
23.  Boysen M, Lovdal O, Tausjo J, Winther F. The value of follow-up in patients treated for squamous cell 
carcinoma of the head and neck. Eur J Cancer. 1992;28:426-430.
24.  Cooney TR, Poulsen MG. Is routine follow-up useful after combined-modality therapy for advanced head 
and neck cancer? Arch Otolaryngol Head Neck Surg. 1999;125:379-382.
25.  Grau JJ, Cuchi A, Traserra J et al. Follow-up study in head and neck cancer: cure rate according to tumor 
location and stage. Oncology. 1997;54:38-42.
26.  de Visscher AV, Manni JJ. Routine long-term follow-up in patients treated with curative intent for 
squamous cell carcinoma of the larynx, pharynx, and oral cavity. Does it make sense? Arch Otolaryngol Head 
Neck Surg. 1994;120:934-939.
27.  Ritoe SC, Krabbe PF, Kaanders JH, van den Hoogen FJ, Verbeek AL, Marres HA. Value of routine 
follow-up for patients cured of laryngeal carcinoma. Cancer. 2004;101:1382-1389.
98
CHAPTER  6.0
Lymph node density in clinically N0 oral 
squamous cell carcinoma: does it have 
predictive value?
Bart M. Wensing
Guido B. van den Broek
Ewald M. Bronkhorst
François J. Dieleman
Matthias A.W. Merkx
Henri A.M. Marres
Frank J.A. van den Hoogen
Submitted
CHAPTER 6
100
abstract
objective
Standard treatment of  patients with squamous cell carcinoma of  the oral cavity 
(SCCOC) and a clinically negative (cN0) neck comprises, amongst others, a selective 
neck dissection. Lymph node density (LND) has recently been shown to be a strong 
predictor of  overall survival and disease-free survival (DFS) in SCCOC. Can LND also 
predict locoregional control (LRC) and DFS accurately in a cN0 SCCOC cohort? 
methods
In a group of  197 patients with cN0 SCCOC, primary tumor characteristics (location, cT 
stage, pt stage, perineural growth, angiolymphatic spread, surgical resection margins, 
degree of  differentiation and growing pattern), as well as LND were retrospectively 
registered. Multivariate analyses were performed to assess the effects of  various factors 
on predicting outcome.
results
LND had an independent, significant negative influence on LRC (p<0.001) and DFS 
(p=0.02) as did diffuse growing pattern and irradical resection borders (LRC, p=0.099 
and p<0.001, respectively; DFS, p=0.019 and p<0.001, respectively). 
conclusions
LND might be of  value in predicting LRC in SCCOC patients with a cN0 neck.
lyMPH nodE dEnsITy In ClInICAlly n0 oRAl squAMous CEll CARCInoMA: 
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introduction
Head and neck squamous cell carcinoma is the sixth most commonly occurring type of  
cancer in the Netherlands. Squamous cell carcinoma of  the oral cavity (SCCOC) alone 
accounts for about 900 new cases a year1 in the netherlands and for about 23,000 new 
cases a year in the united States of  america2. Treatment of  these tumors has gradually 
changed, over the years, from extensive surgery, including radical neck dissection, to a more 
selective one. There is growing evidence that in clinically (c) T1N0 tumors, resection of  
the primary tumor alone, combined with a strict ultrasound-guided fine-needle aspiration 
cytology (FNAC) follow-up of  the neck, has survival rates comparable with patients who 
had an additional elective neck dissection3-6. Treatment in cT2–T4 tumors usually consists 
of  resection of  the primary tumor, combined with selective neck dissection (SND) of  levels 
i, ii, and iii of  the ipsilateral neck, even for palpably and radiographically staged negative 
necks (cN0), as metastatic spread is found in 20–40% of  neck dissection specimens7-10. A 
large number of  neck dissections are therefore unnecessary. Postoperative radiotherapy 
can be indicated, based on histopathologic findings. 
nonetheless, in about 20% of  patients treated in this fashion, local or regional recurrence 
occurs during follow-up. A regional recurrence in the selectively dissected neck during 
follow-up could imply that surgical dissection was not sufficient and that not all the 
lymphatic tissue was removed; if  regional recurrence appears outside the dissected neck, 
this could imply that the SND should have been more extensive. 
theoretically, one could argue that the more nodes are dissected, the smaller the chance 
would be that lymphatic tissue can be left behind; in different fields of  surgical oncology, 
it has been shown that more resected nodes resulted in a higher survival rates (both overall 
survival [OS] and disease-specific survival [DSS])11-14. 
In a small number of  studies of  SCCOC, the concept of  lymph node density (LND) 
recently has been shown to be a strong predictor of  OS and disease-free survival (DFS)15-17. 
lnd can be calculated by dividing the number of  histopathologically proven metastatic 
nodes by the total number of  lymph nodes found in the resection specimen.
Postoperative treatment and follow-up in SCCOC could perhaps be more specifically 
adjusted to the individual patient if  characteristics such as lnd would indicate the 
patient to be at specific risk of  recurrent disease. Postoperative radiotherapy could then, 
possibly, be more individually applied. Moreover, follow-up visits could be planned more 
individually, probably leading to a less intensive and less expensive follow-up routine for 
the majority of  patients. 
the aim of  this study is to evaluate the possible role of  histopathologic features with 
special emphasis on lnd in cn0 SCCoC patients with regard to local and regional 
control (LRC) and DFS. 
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Patients and methods
the medical records of  patients with histopathologically proven SCCoC, who presented 
at the Radboud University Nijmegen Medical Center between January 1, 1992 and 
December 1, 2004 were reviewed. All included patients were staged cN0 and were 
planned for an elective neck dissection of  levels I–III (supraomohyoid neck dissection 
as described by medina and Byers18). All necks were preoperatively examined by means 
of  palpation and ultrasound examination, followed by FNAC on indication (e.g. necrotic 
core, rounded shape, smallest axial diameter >5 mm). Computed tomography and/or 
magnetic resonance imaging scans were carried out, depending on indication, to stage 
the primary tumor. SND was expanded to modified radical neck dissection (MRND) in 
the case of  positive peroperative frozen section sampling (FSS). Patients who had suffered 
from head and neck squamous cell carcinoma in the 5-year period before treatment were 
excluded. Follow- up comprised at least 5 years.
Standardized histopathologic examination of  the neck dissection specimen consisted of  
hematoxylin and eosin staining, node count, lymph node slicing (coupes of  4 µm thickness 
every 2–3 mm) and examination for metastatic disease and extracapsular spread (ECS). 
primary tumors were reviewed for pt stage, degree of  differentiation, invasion of  surgical 
resection margins (e.g. radically, minimally free, and irradically resected tumors [>5 mm 
margin, 1–5 mm margin, and irradical respectively]), presence of  perineural spread, bone 
invasion, angio-invasion and/or lymphatic invasion, and presence of  diffuse growing 
patterns. Perineural spread was defined as tumor cells being present in the perineural 
space or epineurium. Lymphatic and/or vascular invasion was defined as tumor cell 
invasion of  endothelial-lined spaces.
postoperative radiotherapy was advised in the case of  tumor-positive resection margins 
and/or bone invasion by the tumor and/or 2 or more metastatic lymph nodes and/or 
the presence of  ECS in any node as stated by the Dutch practice guidelines ‘Carcinoma 
of  the oral cavity and the oropharynx’1. In the presence of  2 or more of  the following 
characteristics, postoperative radiotherapy was indicated as well: 1 metastatic lymph node, 
close resection margins (<5 mm free of  tumor), angio-lymphatic invasion, perineural 
invasion, and a diffuse growing pattern.
lnd was calculated by dividing the number of  histopathologically proven metastatic 
nodes by the total amount of  nodes dissected. In the case of  bilateral SND I–III, both 
sides were independently scored. Patients were additionally divided into 3 groups (with 
an LND <0.06, 0.06–0.13, and >0.13) based on recent studies by Shrime et al.15 and gil 
et al.16. 
Statistical analysis
Histopathologic examination of  the neck dissection specimen and follow-up were used 
as a reference standard. Cox regression was applied to analyze the relationship between 
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LRC and DFS and potential explanatory variables. The following variables were included 
in the analysis: surgical resection margins of  the primary tumor (radically and marginally 
free versus irradically resected tumors); presence or absence of  perineural spread; angio-
invasion and/or lymphatic invasion; a diffuse growing pattern; tumor-positive nodes 
(found during histopathologic examination of  the neck dissection specimen); degree of  
differentiation; and LND (using 1% LND as unit). To allow comparisons with recent 
literature, the analyses were repeated with the LND as a variable using the defined 
categories. Cox regression analysis was applied with backward selection, with a threshold 
to stay in the model for p-values of  0.10. SPSS 16.0© was used for statistical analysis.
results
Patient characteristics
A total of  197 patients were included in the study. The majority of  tumors (82%) was 
situated in either the floor of  the mouth or the lateral part of  the oral tongue and 84% was 
clinically scored as either T1 or T2. For an overview of  patient characteristics, see table 1.
Neck dissections and LND
twenty-three bilateral neck dissections were performed, of  which 21 Snds of  
regions I–III (220 necks in total); on 2 occasions, an MRND (due to strong suspicion 
or proven peroperative metastatic spread by FSS) was combined with an SND I–III of  
the contralateral neck. In 48 out of  197 cases (49 necks, 24%) metastatic spread was 
present. One patient had histopathologically proven metastatic spread on both sides of  
the bilaterally dissected neck. 
a total of  3786 nodes were examined: 2072 and 1714 nodes on the right and left side, 
respectively. The average number of  nodes per neck thus was 17, with a range of  4–48 
nodes per side of  the neck. In 49 pathologically node positive (pN+) necks, the average 
number of  nodes examined was 20 (range 7–48). There were 79 positive nodes in total; 
on average, 1.6 positive nodes per positive neck. The average LND was 0.10 (10%) in 49 
pN+ necks, with a median of  0.06 (6%); ranging from 0.02 to 0.75 (2–75%). 
Forty-two of  77 (55%) patients undergoing postoperative radiotherapy had a pN0 neck, 
so primary tumor characteristics were the main reason for treatment in these cases. In 
11 cases, ECS was present (7 times in a pN1 neck, 4 times in a pN2b neck); 6 pN1 necks 
were irradiated; the other 20 irradiated pn1 necks had no eCS, but characteristics of  the 
primary tumor were the reason for postoperative radiotherapy. Nine patients had N2b 
necks and were irradiated. Two patients were lost to follow-up because they moved to 
another area. 
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variable n %
gender 
male
female
125
72
63
37
cT stage 
t1
t2
t3
t4
64
103
17
13
32
52
9
7
site 
lateral tongue
floor of  mouth
retromolar trigone
Buccal gingiva
alveolar process
85
76
20
5
11
43
39
10
2
6
Diffuse growing pattern
present
not present
66
131
33.5
66.5
resection margins
radically
marginally free
irradical
100
67
30
50.8
34.0
15.2
grade of  differentiation
poor
moderate
well
22
148
27
11.2
75.1
13.7
Perineural invasion 
present
not present
56
141
28.4
71.6
angio-lymphatic invasion
present
not present
29
168
14.7
85.3
pn stage and percentage of  ecs 
pn0
pn1  
pn2b
pn2c
149 
33 (7)
14 (4)
1 
75.6
16.8 (21.1)
7.1 (28.6)
0.5 
lnD categories
0%
<6%
6–13%
>13%
149
18
22
8
75.6
9.1
11.2
4.1
Table 1. Patient characteristics. 
cN = clinical N stage; pN = pathological N stage; ECS = extracapsular spread; LND = lymph node density
lyMPH nodE dEnsITy In ClInICAlly n0 oRAl squAMous CEll CARCInoMA: 
doEs IT HAvE PREdICTIvE vAluE?
105
CHAPTER
6.0
Locoregional control 
Forty patients (20% of  patients) had local (n=24), regional (n=14), or distant metastases 
(n=2). Fourteen of  these patients presented with regional recurrence (7% of  197 patients). 
Of  149 pN0 necks, 9 patients (6%) developed initial regional recurrent disease, while 3 
of  the 48 patients with pN+ necks (6%) initially presented with regional recurrence. Two 
more patients presented with regional recurrent disease, but also had a second primary 
tumor, making the origin of  regional disease unclear. 
Twenty-four patients initially presented with a local recurrence (12% of  197 patients), 
while the remaining 2 patients had distant metastatic disease without locoregional disease. 
nineteen patients with recurrent disease underwent salvage surgery and 9 of  these 
patients also received additional radiotherapy with curative intent. Six patients received 
radiotherapy only with curative intent, 1 patient was curatively treated in another hospital 
and was lost to follow-up. The remaining 14 patients were treated palliatively.
multivariate Cox regression analysis demonstrated irradical resection borders, a diffuse 
growing pattern, and LND to be of  significant importance concerning the development 
of  recurrent disease (see table 2 and figures 1–3 for details).
hazard ratio  p-value lower 95% ci upper 95% ci
lnD /(%) 1.059 <0.001 1.029 1.090
irradical 
resection border
4.15 <0.001 0.124 0.465
Diffuse growing 
pattern
1.712 0.099 0.904 3.245
Table 2. Resulting end model of  Cox regression analysis on LRC
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Figure 1. Relation between radicality of  the resection border and time to recurrent disease. Curves fitted by 
Cox regression analysis (p<0.001).
Figure 2. Relationship between the presence of  a diffuse growing pattern and time to recurrent disease. Curves 
fitted by Cox regression analysis (p=0.099).
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Figure 3. Relationship between categories of  LND by Shrime et al.15 and time to recurrent disease. Curves 
fitted by Cox regression analysis (p<0.001).
Using the cut-off  points as propagated by Shrime et al.15 and Gil et al.16 regarding lnd, 
one can expect a less successful model, as turning a metric variable into categories reduces 
the information. This was supported by additional analyses. If  the metric variable LND 
is replaced with the categories as defined by Gil et al.16, we find a p-value of  0.062 for 
LND. Using the definition given by Shrime et al.15, LND would show a p-value of  0.037. 
In both cases, this is a considerable higher p value than that for LND as a metric variable. 
note: as the regression model is multiplicative by nature, the effect of  a 10% increase in 
LND, for instance, should be calculated as (hazard ratio [HR] LND)10. So, in this case, 
one would estimate the chance of  a loss of  LRC to be increased by a factor of  1.05910 = 
1.77 if  the LND is 10 percent points higher. The interpretation of  the other two variables 
is simpler. The presence of  a diffuse growing pattern is estimated to increase the chance 
at recurrent disease by a factor 1.712, while an irradical resection increases this chance 
by a factor of  4.15. 
Regarding DFS, multivariate analysis showed LND as a metric variable to lead to a 1.132-
fold increased rate (HR) of  disease-related death (p=0.02). A diffuse growing pattern of  the 
primary tumor showed a 2.453-fold increased rate of  a disease-related death (p=0.019); 
irradical resection of  the primary tumor showed an increased rate of  6.25 (p<0.001) at a 
disease-related death (see table 3 for the resulting end model of  Cox regression analysis).
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hazard ratio p-value lower 95% ci upper 95% ci
lnD /(%) 1.132 0.02 1.047 1.224
irradical resection 
border
6.250 <0.001 0.073 0.348
Diffuse growing 
pattern
2.453 0.019 1.159 5.192
pn+ neck 0.369 0.093 0.115 1.182
Table 3: resulting end model of  Cox regression analysis on dfS
Discussion 
in the current study, a group of  197 cn0 patients with SCCoC was retrospectively 
reviewed to identify the possible predictive value of  LND. LND has been shown to be 
an independent, significant predictive factor for locoregional recurrence and DFS during 
follow-up with a p-value of  <0.001 and 0.02, respectively. The presence of  a diffuse 
growing pattern and irradical resection of  the primary tumor were also independent, 
significant predictive factors regarding LRC and DFS.
the ability to predict tumor behavior in head and neck carcinoma is of  great importance, 
both in pre- and post-treatment decision making. Initial tumor treatment could be more 
individually adjusted; standardized elective neck dissections in cn0 SCCoC patients 
could perhaps be abandoned in a number of  cases, and postoperative treatment and 
follow-up could both be individualized.
our selective group of  cn0 SCCoC patients was comparable with other cohorts with 
regard to male/female ratio, age, distribution of  t stage, localization of  the tumor, 
percentage of  occult metastatic spread found during histopathologic examination, and 
development of  local and regional recurrent disease7, 19. 
irradically resected tumors have repeatedly been proven to result in worse local control 
when compared with radically resected tumors20, 21 as was marginally free resection of  the 
primary tumor20 in a smaller number of  studies.
pathologic t stage has, in a number of  studies, been shown to be a predictor of  recurrent 
disease and shortened dfS22, 23, as has the presence of  a diffuse growing pattern24, 
perineural spread10, 25, 26, and, sporadically, a poor differentiation of  the tumor27. In the 
current study, of  these latter factors, only the presence of  a diffuse growing pattern could 
be confirmed as an independent, significant predictor of  both LRC and DFS. These 
findings add to the existing controversy regarding the possible predictive value of  primary 
tumor characteristics.
in different types of  cancer, an association between the number of  nodes dissected and 
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survival was found11-14, 28, 29. The rationale behind the recently mentioned concept of  
lnd is that the more nodes are dissected and histopathologically reviewed, the bigger 
the chance of  finding possible metastatic disease30 and the higher the prognostic value of  
the neck dissection would be. Agrama et al.30 found that the chance of  finding metastatic 
disease in t1/t2 squamous cell carcinoma of  the head and neck increased with a higher 
number of  nodes found.
Shrime et al.15 claimed LND was a ‘very important prognostic indicator of  survival’: as 
LND increased, survival decreased. They found a strong inverse association of  LND with 
OS. Two cut-off  points were found: an LND <6% was associated with the highest OS; 
patients with an LND of  >12.5% had a significantly worse OS. As already mentioned 
by Shrime et al.15, there are a number of  limitations regarding their recommendations 
based on the SEER (Surveillance, Epidemiology and End Results) database. First of  all, 
no distinction could be made between different kinds of  neck dissection: an Snd of  levels 
i–iii in a cn0 patient could not be distinguished from a classic radical neck dissection 
in a patient with preoperative proof  of  multiple metastases – of  course, preoperative 
estimated survival is already worse for the latter group. Also, the extent of  histopathologic 
review of  the neck dissection specimen could not be retrieved: were all nodes sectioned 
and stained in a standard way? was immunohistochemistry used in a number of  patients? 
if  histopathologic review would be standardized and optimized, perhaps either more 
nodes would be found and examined (leading to a downgraded LND) or, on the other 
hand, the same number of  nodes would be more thoroughly examined, leading to a 
higher amount of  confirmed metastatic nodes (possibly leading to an upgraded LND). 
furthermore, data regarding histopathologic properties of  the primary tumor were not 
available, as was knowledge of  recurrence rates and possible postoperative radiotherapy. 
However, according to the authors, due to the large number and large heterogeneity of  
the included patients, the ‘generalizability’ of  their conclusions would be possible.
A recent study by Gil et al.16 included 386 patients treated for SCCOC (of  which 219 were 
scored pN0), who all had a standardized MRND of  levels I–IV or I–V. In the pN+ cohort, 
LND was found to be significantly associated with OS and DSS: LND ≤6% 5-year OS 
rate was 58% versus 28% for patients with LND >6% (p<0.01). DSS was 65% versus 34% 
in these respective groups. Multivariate analysis confirmed that LND was the single most 
influential factor on DSS. Regarding our current study, the finding that in Gil et al.’s16 
subgroup of  patients who had an SND (cN0), LND also was the most significant predictor 
of  outcome (p<0.04) is of  importance. Moreover, there was no change in LND when 
therapeutic neck dissection was compared with SND. The authors rightly emphasize that 
in case of  more selective standard neck dissections in cn0 patients, it might be estimated 
that LND will be even higher. 
our cohort consisted of  cn0 patients who underwent Snds of  levels i–iii in the vast 
majority, with a nodal yield of  17 that was well below the average yield (35) in the cohort 
of  Gil et al.16, who performed MRND. Shrime et al.15 assumed that the concept of  lnd 
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might be subject to debate in cN0. However, our statistical analysis did point out a highly 
significant predictive value of  LND in the cN0 SCCOC patient regarding LRC and DFS.
The concept of  LND might be a welcome additional prognosticator in the field of  
head and neck squamous cell carcinoma. Of  course, one could argue that LND is a 
modification of  already known and used prognostic factors, such as the pN stage. In the 
Dutch practice guidelines ‘Carcinoma of  the oral cavity and oropharynx’,1 the decision to 
treat a dissected neck postoperatively is based, for instance, on the number of  metastatic 
nodes found: a neck containing 1 metastatic node without eCS basically does not have to 
be treated, while a neck containing 2 or more tumor-positive nodes will have to be treated 
(by radiotherapy). When the concept of  LND is applied, this would lead to the following 
thoughts: if  an Snd i–iii would yield, on average, 20 nodes and a mrnd would yield 
35 nodes, one could estimate that in the case of  1 tumor-positive node (without ECS) 
LND would be 5% and 3%, respectively. However, if  another node would be tumor-
positive, lnd would rise to 10% and 6%, respectively, and chance at lrC would drop 
significantly. Using the pN stage, postoperative radiotherapy would, in either case, be 
advised. However, in the case of  smaller numbers of  nodes dissected, one would more 
readily advise postoperative treatment when compared with pN staging (for instance 
when 1 metastatic node is found in 10–15 dissected nodes [LND 10–7%]; according to 
the guidelines no additional treatment would be necessary, but based on lnd, treatment 
should be given). 
A number of  limitations from this study should be addressed. Unfortunately, the number 
of  patients in whom the tumor depth was registered was too small to include this as a 
variable in our analysis, although a number of  studies stress the importance of  this factor 
regarding LRC and/or survival (both overall and disease-free)31-33. Another renowned 
predictor of  lrC and dfS, the presence of  eCS in lymph node metastasis23, 24, also was 
not included in our analysis because the number of  cases was too small. This latter factor 
is most likely due to our cohort being cN0. Also, a clear distinction between the effect 
of  either local or regional recurrences could not be made, due to the small number of  
patients remaining in each group weakening the statistical value.
given the thoughts above, we believe that the concept of  lnd might be promising, 
also in cn0 cohorts, albeit mainly in patients with only 1 metastatic lymph node and a 
small number of  dissected nodes, because postoperative radiotherapy is already advised 
(according to the guidelines) for 2 or more metastatic lymph nodes. We believe more 
research is needed: more homogeneous patient populations should be investigated, 
histopathologic research techniques should be mentioned as should any postoperative 
treatment. In time, LND could be a useful additional factor in determining possible 
postoperative treatment and follow-up routine in SCCOC. 
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conclusions
The predictability of  LRC in cN0 SCCOC remains a difficult issue: if  tumor behavior 
could be estimated, treatment and follow-up could be better adjusted to individual 
patients. Positive resection margins and a diffuse growing pattern in our cohort 
significantly influenced LRC and DFS negatively, as did LND. The concept of  LND 
might be promising in predicting lrC and dfS in patients suffering from cn0 SCCoC 
and could, in time, be a useful additional factor in determining a patient’s postoperative 
treatment and follow-up routine.
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Treatment of  the neck in squamous cell carcinoma of  the oral cavity (SCCOC) has 
changed over the past decades. However, controversy still exists regarding the treatment 
of  the clinically negative neck (cN0 neck). The choice between (s)elective neck dissection 
(SND) and watchful waiting (accompanied by for instance the use of  ultrasound (US +/- 
fine needle aspiration cytology [FNAC]) during follow-up nowadays still is a difficult one, 
mainly due to the low sensitivities of  preoperative staging techniques. If  a technique can 
repeatedly and in different institutions lower the amount of  false-negative neck stagings 
to 20% or less (confirmed by postoperative histopathological examination), elective neck 
dissections in case of  cn0 SCCoC could be abandoned1. 
The aim of  this thesis was firstly to retrospectively analyze the results of  our own routine 
preoperative staging by US (+/- FNAC) of  the cN0 neck in SCCOC (chapter 2). In 
the search for more accurate preoperative staging techniques in chapters 3 and 4 we 
prospectively evaluated the use of  fluoro deoxy glucose-positron emission tomography 
(FDG-PET) and a new magnetic resonance imaging (MRI) contrast agent (ultra small 
particles of  iron oxide [USPIO]) in cN0 SCCOC respectively.
in chapter 5 our standard follow-up routine in cN0 SCCOC is analyzed. chapter 6 
handles possible prognosticators found by histopathological examination that could be 
able to influence management of  the N0 neck in SCCOC. 
summary of  results
chapter 2 
in our retrospective chart analysis of  224 patients suffering from cn0 SCCoC we found 
a false-negative rate of  22% for US (+/- FNAC). This finding indicates that in our center 
the use of  US (+/- FNAC) approaches the proposed 20% false-negative rate by Weiss 
et al.1 our percentage compares favorably with a number of  studies promoting the 
preoperative use of  Ct and/or mri in neck staging and are in line with a recent meta-
analysis by de Bondt et al.2 the dutch national guideline for oral and oropharyngeal 
SCC advocates the use of  US (+/- FNAC) to stage the neck3. In European studies it has 
repeatedly been shown that US (+/- FNAC) in cN0 SCC shows an at least comparable 
percentage of  false-negative findings when compared to CT and MRI-scanning2, 4-6. We 
strongly advocate the use of  US (+/- FNAC) in preoperative staging of  the cN0 neck in 
SCCOC. In our series the metastatic part in occult metastatic nodes was very small: over 
80% had a smallest diameter between 0 and 5 mm. This small size explains why the nodes 
containing them will be difficult to find by any kind of  preoperative imaging evaluation. Of  
course, standard histopathological techniques can be upgraded (for instance by routinely 
performing multislice sectioning and immunohistochemistry) which would perhaps lead 
to the discovery of  more metastases7.
Clinically T1N0M0 SCCOC showed significantly less occult metastatic spread than 
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cT2N0M0 SCCOC (10 versus 29%). Based on the criteria of  Weiss et al.1, elective neck 
dissection could be abandoned in cT1N0M0 SCCOC. 
chapter 3
prospective analysis of  fdg-pet scanning in cn0 SCCoC showed a disappointingly low 
sensitivity, specificity and accuracy in 28 consecutive patients (33, 76 and 63% respectively). 
Main explanation is probably the small size of  metastatic parts in occult nodes (average 
diameter of  4.3mm), which also causes difficulties while using the ‘standard’ preoperative 
imaging techniques such as US (+/- FNAC), CT and/or MRI. In chapter 2 we already 
mentioned that in a larger group of  patients also the smallest diameter of  metastatic parts 
in tumor-involved lymph nodes was between 0 and 5 mm in more than 80% of  cases. We 
conclude that fdg-pet, mainly due to presence of  micrometastatic spread, probably is 
not suitable as a substitution for any known preoperative imaging technique in staging 
the palpably negative neck in SCCOC. This finding recently was confirmed in a meta-
analysis by Kyzas et al.8 evaluating 32 studies with cn0/cn+ HnSCC patients: it was 
estimated that overall sensitivity was 79% and specificity was 86%. However, in cN0 necks 
sensitivity only reached 50% (specificity was 87%). 
chapter 4
our prospective pilot-analysis of  uSpio-enhanced mri in 11 cn0 SCCoC patients 
showed a large amount of  false-positive results. Only one lymph node was true-positive: 
however, this node was missed by US (+/- FNAC), PET-CT and MRI. Although in cancer 
of  the prostate for instance it has proven (by this technique) to be possible to identify tumor-
positive lymph nodes with a minimal diameter of  2 to 3 millimeters9, 10, in the cn0 neck 
this technique seems less favourable. However, by performing a node-to-node analysis we 
estimated a very high negative predictive value (NPV) and sensitivity for USPIO MRI 
(100% for both). When combined with US (+/- FNAC) with a reknown high specificity in 
our center, it would seem possible to refrain from neck dissection in a number of  patients. 
more research regarding this optional combination is mandatory as is examination of  
possible explanations for the high amount of  false-positive results. In its current form, 
uSpio-enhanced mri is unsuitable as a single preoperative staging technique in patients 
suffering from cN0 SCCOC.
chapter 5
one-hundred-and-ninety-seven patients suffering from cn0 SCCoC were analyzed 
after 5 years of  follow-up. Five-year disease-free survival was 67% and comparable to 
percentages mentioned by other authors. Eighty-three percent of  recurrent disease was 
diagnosed within 2 years; 53% of  patients suffering from recurrent disease visited their 
physician outside the routine follow-up schedule with complaints leading to the finding 
of  recurrent disease. This is in line with findings in different kinds of  cancers but has not 
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yet been mentioned in SCCoC and leads to questions regarding the length and intensity 
of  prescheduled follow-up. As mentioned by many other authors, there are only few 
survivors after recurrent disease (in our study 78% of  patients with recurrence die due 
to their recurrence). Only 3 patients (of  5 in total who could be salvaged and survived) 
presented during prescheduled follow-up visits. We concluded that standard follow-up in 
(cN0) SCCOC in a tertiary referral center could perhaps be limited from 5 to 2 years with 
regards to the finding of  recurrent disease. Of  course other aspects of  follow-up (other 
than the finding of  recurrent disease) like psychological support and guidance for the 
patient will have to be weighed in individual patients before advising to limit routine visits.
chapter 6
we retrospectively reviewed the predictive capacities of  histopathological parameters in 
197 patients with special emphasis on the concept of  lymph node density (LND). LND 
can be calculated by dividing the number of  histopathologically proven metastatic nodes 
by the total number of  lymph nodes found in the resection specimen and has in a small 
number of  studies shown to significantly influence overall and disease-free survival11, 12. 
multivariate analysis showed irradical resection borders, a diffuse growing pattern of  the 
tumor and LND to have significant negative influence on locoregional control (LRC) and 
disease-free survival (DFS). These factors have been mentioned by different authors, as 
well as for instance angiolymphatic invasion, perineural growth, extracapsular spread, 
stage of  the primary tumor, occult metastatic spread, grade of  tumor differentiation and 
tumor depth11-24. 
Intensity of  postoperative treatment (e.g. radiotherapeutic treatment) is currently adjusted 
based on histopathological findings. When reviewing the literature considering prognostic 
or predictive value of  histopathological characteristics there is no consensus on a number 
of  these characteristics, despite many retrospective analyses that have been performed. 
Ideally, a diagnostic technique being able to predict (future) tumor behaviour would be used 
before operating on the patient: extent of  tumoral resection and type of  neck dissection 
(if  necessary) and possibly follow-up routine could be adjusted individually. Regarding 
primary tumor characteristics we believe that the use of  biomarkers in predicting tumoral 
behaviour seems more promising due to the greater representativety and reproducability. 
However, development of  a universally applicable tumor gene expression set will take 
some time; in the mean time the concept of  lnd could be a useful additional factor in 
adjusting postoperative treatment and follow-up routine in a select group of  patients. 
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conclusions and future perspectives
Ultrasound (+/- FNAC) in our institution repeatedly has proven to be a reliable preoperative 
staging technique in cn0 SCCoC4, 25. While searching for a preoperative imaging technique 
being able to outperform US (+/- FNAC), FDG-PET and USPIO-enhanced MRI in its 
current form show no improvement in staging the cN0 neck in SCCOC. The (ultra-) small 
size of  metastatic deposits explains these findings regarding FDG-PET. In case of  USPIO-
enhanced mri more research is needed to identify reasons as to why this technique in the 
cN0 neck reveals a large amount of  false positive findings, in contrast to findings in for 
instance prostate carcinoma9. 
When applying the criteria as posed by Weiss et al.1, the ‘golden standard’ in 
staging the neck in t2-t4n0m0 SCCoC currently remains the selective neck 
dissection of  levels I-III (former supraomohyoid neck dissection) in our institution. 
Clinically t1n0m0 SCCoC can be treated by excision of  the primary tumor alone; if  
done so, the neck should be carefully followed in time (with the use of  US [+/- FNAC]). 
Future application of  the concept of  sentinel lymph node biopsy (SLNB) in small 
(T1/T2N0) tumors of  the oral cavity in our institution is currently being considered. This 
concept in a multi-center study showed a sensitivity of  93% in 134 t1/t2n0 SCCoC and 
oropharyngeal cancer patients26. Paleri et al. in their meta-analyis confirmed a sensitivity of  
94%27. In a recent review by Stoeckli et al.28 it was stated that ‘either SLNB or SLNB assisted 
Snd has the potential to become a new standard of  care for staging and treatment of  cn0 
neck in patients with early SCCOC.’ 
the possibility to predict tumoral behaviour by means of  analyzing characteristics of  
the primary tumor would probably lead to more individually adjusted treatment of  the 
(cN0) neck. However, too much controversy in recent literature exists regarding the use of  
histopathological parameters in choosing between watchful waiting and treatment of  the 
cN0 neck in SCCOC. Our study added to that controversy. We believe that the development 
of  a genetic profile of  SCCOC will be more easily applicable and reproducable and that 
future research regarding prediction of  tumor behaviour should focus on this specific area. 
Currently a multicenter application of  the genetic profile as reported by Roepman et al.29 is 
being analyzed. The concept of  LND might in the meantime be a useful additional factor in 
determining postoperative treatment in a small group of  cN0 SCCOC patients.
Five year disease-specific survival in cN0 SCCOC reaches 67%. Routine follow-up visits 
can be limited to 2 years after treatment of  cn0 SCCoC instead of  the currently used 
5 years, based amongst others on the fact that the majority of  recurrent disease presents 
within 2 years from treatment and salvage treatment of  recurring disease is difficult. With 
a more reliable staging technique and a subsequently more individually adjusted treatment 
we believe that disease specific survival can be raised.
upcoming staging techniques like the use of  for instance SlnB will probably cause a further 
decline in the use of  SND, as will the growing knowledge of  DNA-profiles of  SCCOC.
CHAPTER 7
120
reference list
1.  Weiss MH, Harrison LB, Isaacs RS. Use of  decision analysis in planning a management strategy for the 
stage N0 neck. Arch Otolaryngol Head Neck Surg 1994 Jul;120(7):699-702.
2.  de Bondt RB, Nelemans PJ, Hofman PA, et al. Detection of  lymph node metastases in head and neck cancer: 
a meta-analysis comparing US, USgFNAC, CT and MR imaging. Eur J Radiol 2007 Nov;64(2):266-72.
3.  Knegt PP, Keus RB, Roodenburg JL. [The practice guideline ‘Carcinoma of  the oral cavity and 
oropharynx’]. Ned Tijdschr Geneeskd 2006 Jan 14;150(2):83-8.
4.  van den Hoogen FJ, Manni JJ. Value of  the supraomohyoid neck dissection with frozen section analysis as 
a staging procedure in the clinically negative neck in squamous cell carcinoma of  the oral cavity. Eur Arch 
Otorhinolaryngol 1992;249(3):144-8.
5.  van den Brekel MW, Castelijns JA, Stel HV, et al. Modern imaging techniques and ultrasound-guided 
aspiration cytology for the assessment of  neck node metastases: a prospective comparative study. Eur Arch 
Otorhinolaryngol 1993;250(1):11-7.
6.  van den Brekel MW, Reitsma LC, Quak JJ, et al. Sonographically guided aspiration cytology of  neck 
nodes for selection of  treatment and follow-up in patients with N0 head and neck cancer. AJNR Am J 
Neuroradiol 1999 Oct;20(9):1727-31.
7.  Brouwer J, de Bree R, Comans EF, et al. Positron emission tomography using [18F]fluorodeoxyglucose 
(FDG-PET) in the clinically negative neck: is it likely to be superior? Eur Arch Otorhinolaryngol 2004 
Oct;261(9):479-83.
8.  Kyzas PA, Evangelou E, axa-Kyza D, et al. 18F-fluorodeoxyglucose positron emission tomography 
to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-
analysis. J Natl Cancer Inst 2008 May 21;100(10):712-20.
9.  Heesakkers RA, Hovels AM, Jager GJ, et al. MRI with a lymph-node-specific contrast agent as an alternative 
to CT scan and lymph-node dissection in patients with prostate cancer: a prospective multicohort study. 
Lancet Oncol 2008 Sep;9(9):850-6.
10.  Barentsz JO, Futterer JJ, Takahashi S. Use of  ultrasmall superparamagnetic iron oxide in lymph node MR 
imaging in prostate cancer patients. Eur J Radiol 2007 Sep;63(3):369-72.
11.  Gil Z, Carlson DL, Boyle JO, et al. Lymph node density is a significant predictor of  outcome in patients 
with oral cancer. Cancer 2009 Dec 15;115(24):5700-10.
12.  Shrime MG, Ma C, Gullane PJ, et al. Impact of  nodal ratio on survival in squamous cell carcinoma of  the 
oral cavity. Head Neck 2009 Sep;31(9):1129-36.
13.  Spiro RH, Huvos AG, Wong GY, et al. Predictive value of  tumor thickness in squamous carcinoma 
confined to the tongue and floor of  the mouth. Am J Surg 1986 Oct;152(4):345-50.
14.  Pentenero M, Gandolfo S, Carrozzo M. Importance of  tumor thickness and depth of  invasion in nodal 
involvement and prognosis of  oral squamous cell carcinoma: a review of  the literature. Head Neck 2005 
Dec;27(12):1080-91.
15.  Leemans CR, Tiwari R, Nauta JJ, et al. Recurrence at the primary site in head and neck cancer and the 
significance of  neck lymph node metastases as a prognostic factor. Cancer 1994 Jan 1;73(1):187-90.
suMMARy, ConClusIons And fuTuRE PERsPECTIvEs
121
CHAPTER
7.0
16.  Chen TY, Emrich LJ, Driscoll DL. The clinical significance of  pathological findings in surgically 
resected margins of  the primary tumor in head and neck carcinoma. Int J Radiat Oncol Biol Phys 1987 
Jun;13(6):833-7.
17.  Parsons JT, Mendenhall WM, Stringer SP, et al. An analysis of  factors influencing the outcome of  
postoperative irradiation for squamous cell carcinoma of  the oral cavity. Int J Radiat Oncol Biol Phys 1997 
Aug 1;39(1):137-48.
18.  Patel RS, Clark JR, Dirven R, et al. Prognostic factors in the surgical treatment of  patients with oral 
carcinoma. ANZ J Surg 2009 Jan;79(1-2):19-22.
19.  Ravasz LA, Slootweg PJ, Hordijk GJ, et al. The status of  the resection margin as a prognostic factor in the 
treatment of  head and neck carcinoma. J Craniomaxillofac Surg 1991 Oct;19(7):314-8.
20.  Fagan JJ, Collins B, Barnes L, et al. Perineural invasion in squamous cell carcinoma of  the head and neck. 
Arch Otolaryngol Head Neck Surg 1998 Jun;124(6):637-40.
21.  Rahima B, Shingaki S, Nagata M, et al. Prognostic significance of  perineural invasion in oral and 
oropharyngeal carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004 Apr;97(4):423-31.
22.  Liao CT, Lin CY, Fan KH, et al. Identification of  a High-Risk Group Among Patients With Oral Cavity 
Squamous Cell Carcinoma and pT1-2N0 Disease. Int J Radiat Oncol Biol Phys 2010 Nov 13.
23.  Sparano A, Weinstein G, Chalian A, et al. Multivariate predictors of  occult neck metastasis in early oral 
tongue cancer. Otolaryngol Head Neck Surg 2004 Oct;131(4):472-6.
24.  O’Brien CJ, Lauer CS, Fredricks S, et al. Tumor thickness influences prognosis of  T1 and T2 oral cavity 
cancer--but what thickness? Head Neck 2003 Nov;25(11):937-45.
25.  Wensing BM, Merkx MA, de Wilde PC, et al. Assessment of  preoperative ultrasonography of  the neck and 
elective neck dissection in patients with oral squamous cell carcinoma. Oral Oncol 2010 Feb;46(2):87-91.
26.  Ross GL, Soutar DS, Gordon MD, et al. Sentinel node biopsy in head and neck cancer: preliminary results 
of  a multicenter trial. Ann Surg Oncol 2004 Jul;11(7):690-6.
27.  Paleri V, Rees G, Arullendran P, et al. Sentinel node biopsy in squamous cell cancer of  the oral cavity and 
oral pharynx: a diagnostic meta-analysis. Head Neck 2005 Sep;27(9):739-47.
28.  Stoeckli SJ, Alkureishi LW, Ross GL. Sentinel node biopsy for early oral and oropharyngeal squamous cell 
carcinoma. Eur Arch Otorhinolaryngol 2009 Jun;266(6):787-93.
29.  Roepman P, Wessels LF, Kettelarij N, et al. An expression profile for diagnosis of  lymph node metastases 
from primary head and neck squamous cell carcinomas. Nat Genet 2005 Feb;37(2):182-6.
122
CHAPTER  8.0
Samenvatting
CHAPTER 8
124
Het plaveiselcelcarcinoom van de mondholte van het squameuze type (‘squamous cell 
carcinoma of the oral cavity [SCCOC]’) komt voor bij ongeveer 500 nieuwe patiënten 
per jaar in nederland1 (0,9% van alle soorten kanker in Nederland). Roken en het gebruik 
van alcohol zijn predisponerende factoren voor het ontwikkelen van dit type kanker2-4. 
De behandeling van deze tumor is in principe chirurgisch. Het SCCOC metastaseert als 
eerste naar de nabije lymfeklieren in de hals aan de kant van het lichaam waar ook de 
primaire tumor zit. Het hebben van lymfekliermetastasen is de belangrijkste voorspeller 
voor de overleving5, 6. Hierom is het vroegtijdig opsporen en adequaat behandelen van 
halskliermetastasen van groot belang. 
De meest interessante groep patiënten met een vastgesteld SCCOC betreft de patiënten 
die met gebruikmaking van de momenteel gangbare stadiëringstechnieken geen 
aantoonbare metastasen in de hals hebben (‘cN0 hals’); uit literatuur blijkt dat in deze 
groep patiënten bij ongeveer 25-30% toch sprake blijkt van metastasen7-9, die met behulp 
van een operatie, waarbij een aantal lymfeklieren uit de hals verwijderd en daaropvolgend 
histopathologisch onderzocht wordt, wel aangetoond kunnen worden. Er bestaat een 
internationale consensus gebaseerd op een beslissingsanalyse10, waarin beschreven staat 
dat wanneer het percentage preoperatief niet detecteerbare (‘klinisch occulte’) metastasen 
onder de 20% gebracht kan worden, er afgezien kan worden van een nu standaard 
uitgevoerde stadiërende beperkte (selectieve) halsklierdissectie van halsregio’s I t/m III 
(selectieve halsklierdissectie [SHKD] I-III).
Deze groep van patiënten met een cN0 SCCOC, is het onderwerp van deze dissertatie. 
de onderzoeken beschreven in dit proefschrift proberen een antwoord te krijgen op 
een aantal vragen, waarbij de zoektocht naar een goed toe te passen preoperatieve 
stadiëringstechniek die het aantal occulte metastasen onder de 20% brengt, centraal staat.
na een korte bespreking van de epidemiologie, etiologie en anatomie wordt in de 
inleiding (hoofdstuk 1) besproken welke technieken er voorhanden zijn om metastasen 
in de hals aan te tonen danwel uit te sluiten. De geschiedenis van de halsklierdissectie 
wordt besproken aangezien een SHKd met daarop volgend histopathologisch 
onderzoek op dit moment nog steeds de ‘gouden standaard’ is voor het opsporen van 
eventueel occult aanwezige halskliermetastasen bij patiënten met een cN0 SCCOC. 
Vervolgens worden de meest gangbare preoperatieve technieken besproken. De niet-
invasieve technieken palpatie, echografisch onderzoek (ultrasound [US]), de computed 
tomography (CT) en magnetic resonance imaging (MRI) scan en de fluoro deoxy glucose 
positron emission tomography (FDG-PET) scan worden besproken. Tevens worden twee 
(minimaal) invasieve technieken besproken: US aangevuld met dunne naald aspiratie 
cytologie (fine needle aspiration cytology [FNAC]) en de sentinel lymph node biopsy 
(SLNB). Tot slot wordt kort ingegaan op de voorspellende waarde van histopathologische 
kenmerken van het SCCOC en de mogelijke (toekomstige) rol van een genetisch profiel, 
welke voorspellend zouden kunnen zijn voor het gedrag van dit soort tumoren. 
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in hoofdstuk 2 beschrijven we een retrospectieve analyse van 224 patiënten die 
behandeld zijn in het UMC St Radboud voor een cN0 SCCOC met palpatie en US (+/- 
FNAC) voorafgaand aan de SHKD I-III. We vonden in 22% van de gevallen metastasen 
bij het postoperatieve histopathologische onderzoek: het eerder genoemde streefgetal van 
20% wordt met behulp van palpatie en US (+/- FNAC) dus benaderd binnen onze kliniek. 
de gevonden metastasen bleken in 80% van de gevallen kleiner te zijn dan 5 mm in 
doorsnede; dit verklaart onzes inziens waarom eigenlijk alle huidige beeldvormende 
modaliteiten grote moeite hebben met het aantonen van niet palpabele metastasen. Voorts 
vonden we voor kleine tumoren (T1, ongeacht locatie) een beduidend lager percentage 
aan occulte metastasen dan voor T2 tumoren (10 versus 29% respectievelijk). Het lijkt er 
dus zeer sterk op dat in geval van een ct1n0m0 SCCoC er afgezien kan worden van de 
standaard stadiërende selectieve halsklierdissectie.
in hoofdstuk 3 voerden we een prospectieve analyse uit van de preoperatieve 
stadiëring met behulp van de FDG-PET scan bij 28 patiënten met een cN0 SCCOC, 
welke vervolgens op de gebruikelijke wijze (palpatie en US [+/- FNAC], gevolgd door 
SHKD I-III) gestadiëerd en behandeld werden. Wederom bleek de gemiddelde minimale 
diameter van de gevonden metastasen met 4.3 mm erg beperkt en dit gegeven droegen 
wij aan als voornaamste reden om de matige sensitiviteit, specificiteit en accuracy (33, 76 
en 63% respectievelijk) te verklaren. Wij concludeerden dan ook dat, voornamelijk gezien 
de te verwachten zeer kleine metastasen in deze selectieve patiëntengroep, de FDG-PET 
scan niet geschikt is voor het verfijnen van de stadiëring van de cN0 hals.
hoofdstuk 4 behandelt een prospectieve pilot study naar een nieuw contrastmiddel 
gebruikt bij MRI scans: ultra small particles of iron oxide (USPIO). Toepassing hiervan 
binnen het umC St radboud heeft bij het prostaatcarcinoom geleid tot een daling van 
het aantal occulte metastasen en daarmee het afschaffen van de electieve klierdissectie 
in het kleine bekken11, 12. Bij 11 patiënten met een cN0 SCCOC werd slechts 1 klier als 
terecht positief gescoord; een veelvoud daarvan was vals positief. Een ‘node-by-node’ 
analyse toonde een zeer hoge negatief voorspellende waarde (NVW) en sensitiviteit 
aan van 100%. Een mogelijke combinatie met US (+/- FNAC), waarbij juist een hoge 
specificiteit gehaald kan worden, zou in de toekomst mogelijk kunnen leiden tot het afzien 
van de standaard SHKD bij patiënten waarbij zowel USPIO-MRI als US (+/- FNAC) 
geen aanwijzingen voor metastasen laat zien. Als enige preoperatieve stadiëringsmethode 
lijkt USPIO-MRI bij cN0 SCCOC ongeschikt.
in hoofdstuk 5 wordt de 5-jaars-follow-up van een groep van 197 patiënten met een 
cN0 SCCOC onder de loep genomen. Ziektevrije 5-jaars-overleving was 67% voor deze 
groep patiënten. Drieëntachtig procent van alle recidieven (lokaal danwel regionaal) 
blijkt zich binnen 2 jaar te openbaren. Van de mensen met een lokaal danwel regionaal 
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recidief blijkt 53% zich op eigen gelegenheid, dus buiten de reguliere controleafspraken 
om, te melden met klachten die leiden tot de ontdekking van het recidief. Dit is voor deze 
groep patiënten nog niet eerder beschreven en leidt tot vragen aangaande de reguliere 
follow-up-visites: moeten deze patiënten met deze frequentie komen? Moeten we ze wel 5 
jaar controleren? Hierbij blijkt tevens dat 78% van alle patiënten met een lokaal, danwel 
regionaal recidief uiteindelijk, onafhankelijk van het type behandeling voor hun recidief, 
overlijdt. Hieruit concluderen wij dat het standaard follow-up schema binnen een tertiair 
oncologisch centrum mogelijk aangepast kan worden: van 5 naar 2 jaar van reguliere 
controles lijkt vanuit het oogpunt van overleving een reële optie. Uiteraard zullen andere 
belangrijke zaken als psychosociale aspecten eveneens meegenomen moeten worden bij 
toekomstige afwegingen. 
in hoofdstuk 6 beschrijven we in retrospect de voorspellende waarde van 
histopathologische kenmerken bij 197 patiënten met een cN0 SCCOC, met speciale 
aandacht voor het concept van de ‘lymfeklier dichtheid’ (lymph node density, 
[LND]). De LND kan berekend worden door het aantal bewezen (met behulp van 
histopathologisch onderzoek) metastatische lymfeklieren te delen door het totaal 
aantal gevonden lymfeklieren in een geopereerde hals. Deze LND heeft in een aantal 
studies bewezen een significante invloed te hebben op de overleving (zowel overall 
als ziektespecifiek) van patiënten met (onder anderen) een mondholtetumor13,14. 
een multivariate analyse bij onze groep patienten toont aan dat een irradicale resectie 
van de tumor, een sprieterig groeipatroon van de tumor en de lnd allen een verhoogde 
kans op een recidief en tevens een verlaging van de ziektevrije overleving geven. Deze 
factoren zijn allen door andere auteurs genoemd, evenals een aantal andere histologische 
kenmerken van de primaire tumor en de geopereerde hals, welke in onze analyse niet 
van significante waarde waren of niet bekeken konden worden: bloed- of lymfevatinvasie, 
stadium van de primaire tumor, tumordifferentiatie, perineurale groei van de tumor, 
tumordiepte, de aanwezigheid van metastasen in de hals en extracapsulaire verspreiding 
van tumor buiten een metastase6, 13-24.
Het ondergaan van en de intensiteit van een post-operatieve behandeling (radiotherapie) 
is momenteel gebaseerd op aanwezigheid van (een aantal van) deze eerder genoemde 
kenmerken. Over de waarde van een aantal van deze genoemde kenmerken van de primaire 
tumor echter bestaat in de literatuur geen consensus ondanks een grote hoeveelheid aan 
uitgevoerde (met name) retrospectieve studies. Idealiter zou in de diagnostische fase een test 
bestaan, waarmee het gedrag van een tumor beter ingeschat kan worden; hiermee zou een 
behandelplan gemaakt kunnen worden dat specifiek op die ene patiënt is gericht. ‘Maatwerk’ 
zou hiermee mogelijk zijn en mogelijk kunnen leiden tot een flinke afname van het aantal 
verrichte electieve halsklierdissecties en mogelijk ook tot een aangepast follow-up schema. 
Wij geloven dat ‘maatwerk’ mogelijk op termijn mogelijk zal zijn; hoogstwaarschijnlijk 
zal het gebruik van zogenaamde ‘biomarkers’ (een genetisch profiel van een tumor) hierin 
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een (veel) grotere rol spelen dan de hierboven omschreven histologische kenmerken 
van de primaire tumor. Voordat er een panklaar en universeel toepasbaar genprofiel 
beschikbaar zal zijn, zal er nog wel wat tijd verstrijken: in die tussenliggende periode 
zou het concept van de lnd mogelijk een bruikbare additionele factor zijn in het 
postoperatieve behandel- en follow-upschema bij chirurgisch behandelde patiënten met 
een cN0 mondholtecarcinoom.
conclusies 
Het gebruik van US (+/- FNAC) heeft binnen onze kliniek bewezen nog steeds tot 
één van de meest betrouwbare preoperatieve stadiëringsmethoden bij cN0 SCCOC te 
behoren8, 25. Op zoek naar een techniek die ertoe zou kunnen leiden af te zien van de 
standaard uitgevoerde stadiërende halsklierdissectie, lijken FDG-PET en USPIO MRI 
niet in staat om deze te vervangen en het percentage patiënten met occulte metastasen 
in deze groep categorisch onder de 20 procent te brengen. In het geval van FDG-PET 
lijkt de verklaring voor het matige presteren te liggen in het beperkte volume van de 
gemiste metastasen. Wat betreft de USPIO MRI hebben we geen duidelijke verklaring 
kunnen vinden voor het grote aantal vals-positieve bevindingen in cN0 SCCOC. Meer 
onderzoek zal hiernaar nodig zijn, evenals een studie naar een combinatie met uS 
(+/- FNAC) als preoperatieve stadiëringscombinatie; dit in verband met de zeer hoge 
NVW en sensitiviteit van USPIO MRI en juist de hoge specificiteit van US (+/- FNAC). 
Gezien de kleine (10%) kans op occulte metastasen, ongeacht de locatie van de tumor en 
het afwezig blijven van significant meer recidieven in deze groep, kan afgezien worden 
van een standaard SHKD I-III bij cT1N0 SCCOC. In T2-T4 tumoren blijft een SHKD 
I-III behoren tot de standaard behandeling. De mogelijkheid van het toepassen van het 
concept van SlnB in het geval van t1-t2 tumoren wordt momenteel overwogen binnen 
onze kliniek.
Wat betreft de follow-up van deze groep cN0 SCCOC patiënten is gebleken dat, gericht 
op survival, de standaard follow-up van 5 jaar met routine controles teruggebracht zou 
kunnen worden naar 2 jaar, aangezien verreweg de meeste recidieven binnen 2 jaar 
optreden en patiënten in meer dan de helft van de gevallen zelf aan de bel trekken met 
klachten leidend tot de ontdekking van een recidief. 
Onze studie identificeerde een 3-tal kenmerken van primaire tumoren (en de geopereerde 
hals) die leidden tot een significant hogere kans op ontwikkeling van een recidief en 
verlaging van de ziektespecifieke overleving (irradicale resectie van de tumor, een 
sprieterige groeiwijze van de tumor en LND); het concept van de LND zou mogelijk voor 
een kleine groep patiënten kunnen leiden tot een meer ‘op maat gemaakte’ postoperatieve 
behandeling. 
Wij achten de kans op het succesvol ontwikkelen van een genetisch profiel (een aantal 
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dna-kenmerken van tumorcellen wat voorspelt hoe een bepaalde tumor zich zal 
gedragen) van tumoren groot en denken dat toekomstige inspanningen bij het zoeken 
naar een bepaalde ‘voorspelbaarheid’ en daarmee meer individuele behandeling van 
patiënten met bijvoorbeeld SCCOC, in deze richting zou moeten zijn. 
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graag wil ik van de gelegenheid gebruik maken om op deze plaats iedereen te bedanken, 
die op welke manier dan ook een bijdrage heeft geleverd aan de totstandkoming van dit 
proefschrift. Een aantal mensen wil ik in het bijzonder noemen.
Hooggeachte professor Marres, beste Henri, mede (en waarschijnlijk zelfs met name) 
door jouw steun heb ik de kans gekregen voor ons prachtige vak te kiezen. Een bijkomend 
voordeel (en overigens voorwaarde) was dit mooie onderzoek wat uiteindelijk toch op een 
zeer bevredigende wijze is afgerond. Ik heb bewondering voor het feit dat je, ondanks 
je tot de nok gevulde werkweken toch altijd, ook al was dat ’s nachts, even tijd vond om 
‘een artikeltje’ door te lezen en van commentaar te voorzien. Ik hoop dat we de komende 
jaren nog op vele vlakken samen kunnen blijven werken.
Hooggeachte professor Merkx, beste Thijs, ik ken geen snellere corrector dan jij. Je 
was/bent altijd bereid om te overleggen, reageert extreem snel (ook op de zwarte piste 
of vanuit Tanzania) op emails en hebt vele waardevolle suggesties gedaan voor dit 
onderzoek. Zonder jouw bijdrage was dit niet zo’n mooi boekje geworden!
Zeer geachte doctor van den Hoogen, beste Frank, als copromotor een (af en toe 
eigenwijze) promovendus begeleiden bij het schrijven van een proefschrift mag met recht 
een uitdaging genoemd worden. Een uitdaging die je met plezier bent aangegaan en 
waarvan dit boekje het eindresultaat is. Ik ben je dankbaar voor de geboden steun en met 
name voor de leuke en vruchtbare brainstormsessies die we gehad hebben, afgewisseld 
met het bekijken van mooie foto’s uit verre oorden en de gesprekken over andere zaken 
dan werk. ‘De boog kan immers niet altijd gespannen staan’, iets waarvan ik me terdege 
bewust ben geworden in deze jaren en wat ik in mijn verdere carrière ter harte zal 
nemen. 
alle co-auteurs, zonder wie de artikelen die dit boekje sieren niet op deze manier tot 
stand zouden zijn gekomen: dr. Peter de Wilde, dr. Wouter Vogel, dr. Ernst Postema, 
professor Wim Oyen, professor Paul Krabbe, dr.ir. Willem Deserno, dr. Bert-Jan de 
Bondt, professor Jelle Barentsz, dr. Guido van den Broek, François Dieleman en dr.ir. 
Ewald Bronkhorst. Heel veel dank!
Het leeuwendeel van dit project heeft in mijn assistententijd plaatsgevonden en ik wil 
eenieder met wie ik de opleiding heb gevolgd danken voor de met name zeer gezellige 
jaren en danken voor jullie ‘luisterende oren’. Vooral mijn research-maatjes van het eerste 
uur, Stijn, rutger, olivier en godelieve hebben ervoor gezorgd dat ik een vertrouwde en 
mooie start had binnen de KNO. Dankjulliewel!
dAnkWooRd
136
nelleke wensing-Bisseling, alle credits voor de prachtige layout van dit boekje zijn voor 
jou! Geweldig dat je, ook zelfs in de late uurtjes in de week van je op handen zijnde 
bruiloft, nog tijd hebt gevonden om van deze brij van woorden, tabellen en figuren, zo 
iets moois te maken. Het kan niet anders dan dat nelleke-ART© een succes gaat worden. 
Ik sta bij je in het krijt!
alle vele lieve vrienden en vriendinnen die de afgelopen jaren regelmatig informeerden 
naar ‘de promotie’ (soms ook wel eens verward met ‘de opleiding’, of ‘de studie’, of de 
'KNO'): dank voor jullie interesse en bovenal jullie vriendschap! 
Mijn lieve paranimfen, Marijke en Daan. 
marijke, toen ik je tijdens het pannenkoeken eten vroeg om mijn paranimfe te zijn voelde 
dat voor mij als de ultieme bevestiging van onze al meer dan 14 jaar durende vriendschap 
die begon met ‘ARGWAAN’: laten we er nog een boel meer jaren aan vastplakken! 
Lieve Daan, mijn ‘grote kleine broer’. Ik verheug me op het feit dat we weer in elkaars 
buurt komen wonen en op alle leuke dingen die we nu (nog) makkelijker kunnen 
ondernemen! Je bent mijn beste vriend en zult dat altijd blijven.
Lieve Fred en Bianca, wat hadden we dit feestje graag met Joke erbij willen vieren. Helaas 
mag het niet zo zijn, maar in onze gedachten staat ze vooraan bij de festiviteiten! Ik mag 
me gelukkig prijzen met zo’n werkelijk fantastische schoonvader en zwaagster (☺) en ik 
hoop dat we samen vanaf nu vooral weer heel veel leuke en mooie dingen gaan beleven!
lieve pa en ma, jullie hebben mij alle kansen gegeven om iets te bereiken in het leven en 
te worden tot wie ik ben: dit boekje is voor het overgrote deel een tastbaar resultaat van 
de inspanningen die jullie hebben geleverd om mij goed terecht te laten komen. Ik hoop 
de liefde en steun die ik van jullie heb gekregen door te kunnen geven aan onze kinderen, 
jullie zijn geweldig!
Lieve Lin, traditiegetrouw zijn de laatste regels van dit boekje voor jou. Ik zou een 
soortgelijk boekwerk kunnen schrijven over hoe geweldig, leuk, lief en mooi ik je vind (en 
daarmee veul sneller klaar zijn), maar dat komt misschien later nog eens... Voor nu heb 
ik vooral zin in onze toekomst! 
Ik hou van je.
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Bart Matthijs Wensing werd op 11 april 1979 geboren te Arnhem. In 1997 slaagde hij 
voor het eindexamen Gymnasium op het Stedelijk Gymnasium Arnhem. Hierna kon hij 
meteen beginnen aan de studie geneeskunde te nijmegen, waar hij in november 2003 zijn 
artsenbul uitgereikt kreeg. Naar aanleiding van een keuze-coschap KNO-heelkunde in 
het rijnstate ziekenhuis arnhem en een wetenschappelijke stage in het umC St radboud 
Nijmegen op het gebied van de KNO-heelkunde was de interesse voor ‘de KNO’ geboren. 
Begin 2004 werd hij aangenomen (per maart 2004) als arts-onderzoeker met uitzicht op 
een opleidingsplaats KNO aan het UMC St Radboud Nijmegen. Na een jaar onderzoek, 
wat uiteindelijk geleid heeft tot dit proefschrift, werd op 14 maart 2005 aangevangen met 
de opleiding tot KNO-arts, welke op 14 maart 2010 afgerond werd. 
na een reis door Zuid-amerika volgend op de afronding van zijn opleiding is hij per 
1 juli 2010 begonnen met een fellowship hoofd/hals oncologie aan het umC St radboud 
Nijmegen. De verwachting is dat hij dit fellowship op 1 juli 2012 zal afronden en toe zal 
treden tot de maatschap Keel-, neus- en oorheelkunde en Heelkunde van het Hoofd-/
Halsgebied van het Rijnstate ziekenhuis te Arnhem.
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Stellingen behorende bij het proefschrift ‘The clinically 
negative neck in oral squamous cell carcinoma 
An update on preoperative imaging and follow-up’
1.  Het echografisch onderzoek van de hals, al dan niet aangevuld met een 
cytologische punctie, heeft over de jaren heen bewezen de meest betrouwbare 
preoperatieve beeldvormende techniek te zijn in geval van een palpatoir 
negatieve hals bij patiënten met een mondholtecarcinoom. (Dit proefschrift)
2.  Het uitvoeren van een electieve halsklierdissectie zou in het geval van een 
klinische T1N0 mondholtetumor achterwege gelaten kunnen worden.  
(Dit proefschrift)
3.  Het regelmatig missen van klinisch occulte metastasen bij mondholtetumoren bij 
gebruik van gangbare radiologische entiteiten is voor een groot deel te verklaren 
door de zeer beperkte afmetingen van het metastatische deel in de lymfeklier.  
(Dit proefschrift)
4.  Moderne beeldvormingstechnieken zoals FDG-PET scanning en toevoegen van 
USPIO bij MRI scanning zorgen preoperatief niet voor een betere detectie van 
occulte metastasen bij mondholtetumoren. (Dit proefschrift)
5.  De standaard followup bij patiënten met een mondholtetumor zou mogelijk 
verder ingekort kunnen worden van 5 naar 2 of 3 jaar. (Dit proefschrift)
6.  In afwachting van routinematig te gebruiken tumormarkers is de Lymph Node 
Density mogelijk een nieuwe additionele waarde die gebruikt kan worden voor 
het voorspellen van locoregionale controle en ziektespecifieke overleving bij 
chirurgisch behandelde mondholtetumoren. (Dit proefschrift)
7.  Een wetenschapper is een bijzondere vogel: eerst broedt hij en vervolgens legt hij 
een ei. (Ferwerda)
8.  De meeste ziekten gaan vanzelf over, als je er maar niet op tijd bij bent. 
 (Nederlandse dokterswijsheid)
9. Rookworst zonder R is ook worst. (Biek Peters)
10.  Oogletsels bij squash kunnen worden voorkomen door de bal voortdurend in het 
oog te houden.
11.  Na het spel gaan de koning en de pion in hetzelfde doosje. (Italiaans spreekwoord)
12. Als tijd geld is, hoe arm ben je dan als je géén tijd hebt.
